MX2007009151A - Additives for bodywashes. - Google Patents

Abstract

The invention encompasses additives for bodywashes. The additive may contain a sunscreen. The additive may contain 2, 3, or more than three sunscreens. Optionally, one or more of the sunscreens may be encapsulated. The invention further encompasses methods of making and using additives and bodywashes containing an additive, e.g., an additive containing a sunscreen.

Description

ADDITIVES FOR BODY BATHS CROSS REFERENCE This application claims the benefit of the Provisional Application of E.U. No. 60 / 648,961 filed on January 31, 2005 and the US Patent Applications. Nos. 11 / 076,565; 11 / 076,089; 11 / 076,517; 11 / 076,088; and 11 / 076,507, all filed on March 8, 2005, all of which are incorporated herein by reference in their entirety. BACKGROUND OF THE INVENTION Exposure to ultraviolet light, mainly through exposure to sunlight, produces a number of harmful effects including premature aging of the skin, loss of elasticity, wrinkles, dryness and increased risk of developing cancer. of skin. Currently, a number of sunblock products are sold to protect against these harmful effects. All these products contain agents known to filter out some of the harmful sun's rays incorporated in creams, ointments, lotions, solutions or suspensions. Such products are applied just before sun exposure, provide short-term protection and are removed with normal bathing, washing or peeling of the skin. The soap in the form of body bath has been used for years to remove the oil due to its composition surfactant and charges associated A normal soap contains both charges of a positive and negative nature. Although attempts have been made to combine sunscreens with soaps (? .e., Surfactant agents), none have provided an ideal combination of a high sun protection factor (SPF) and a long lasting effect on a composition that maintains its integrity. . Other additives besides sunscreen are also potentially useful when applied together with a body bath, but few products currently use this potential. The present invention addresses these shortcomings. SUMMARY OF THE INVENTION The invention encompasses body baths containing an additive. The additive may contain a sunscreen. The invention also encompasses methods for making and using bodily baths containing an additive, e.g., an additive containing a sunscreen. In one aspect, the present invention provides a body bath containing an additive comprising a sunscreen, wherein, after a single application of the body bath to the skin and rinsing, the skin is protected from sunlight with a Average SPF of at least about 15. In some embodiments, the SPF of 15 is maintained by an average of at least about 4 hours after rinsing. In some modalities, the protector Solar is encapsulated, e.g., in microcapsules of liquid colloid gel. In some embodiments, the sunscreen is an organic sunscreen that is aminobenzoic acid, avobenzone, cinoxate, dioxybenzone, homosalate, methyl anthranilate, octocplene, octyl methoxycinnamate, octyl salicylate, oxybenzone, padimate 0, phenylbenzimidazole sulfonic acid, sulisobenzone or trolamine salicylate. In some embodiments, the sunscreen is a cinnamate derivative. In some embodiments, the additive contains 3 organic sunblocks. In some embodiments the 3 organic sunblockers are selected from the group consisting of aminobenzoic acid, avobenzone, cinoxate, dioxybenzone, homosalate, methyl anthranilate, octocplene, octyl methoxycinnamate, octyl salicylate, oxybenzone, padimate 0, phenylbenzimidazole sulfonic acid, sulisobenzone and trolamine salicylate. . The embodiments may also contain an inorganic sunscreen. In some embodiments, the inorganic sunscreen is selected from the group consisting of zinc oxide and titanium dioxide. In some embodiments, the sunscreen is a sunscreen that absorbs UVB and the composition also contains a UVA absorbing sunscreen and a physical sunblock, wherein the UVB-absorbing sunscreen is selected from the group consisting of aminobenzoic acid, cinoxate, dioxybenzone, homosalate, octocplene, octyl methoxycinnamate, octyl salicylate, oxybenzone, padimate 0, phenylbenzimidazole sulfonic acid, sulisobenzone and trolamine salicylate; the UVA absorbent sunscreen is selected from the group consisting of avobenzone and methyl anthranilate; and the physical blocker sunscreen is selected from the group consisting of titanium dioxide and zinc oxide. The embodiments may also contain a cationic polymer. In some embodiments, the cationic polymer is a polyuater. In some modalities, the polyquaternium is polyquaternium -4, -7, -11. -22, -27, -44, -51 or -64. In preferred embodiments, the cationic polymer is pol? Quatern? O-. The embodiments may also contain a film former, a preservative and / or a stable antioxidant when exposed to sunlight. In another aspect, the invention provides a body bath containing an additive that contains a sunscreen, where, after application of the body bath to the skin and rinsing, the sunscreen penetrates an average no more than 30 microns in the skin after the application followed by rinsing. In some embodiments of this aspect, after application of the body bath to the skin and of rinsing, the skin is protected from sunlight with an average SPF of at least about 15. In a further aspect, the invention provides a body bath comprising a UVA absorbing sunscreen, a UVB absorbing sunscreen, a physical sunblock and a cationic polymer. In some embodiments, the UVB-absorbing sunscreen is selected from the group consisting of aminobenzoic acid, cinoxate, dioxybenzone, homosalate, octocrylene, octyl methoxycinnamate, octyl salicylate, oxybenzone, padimate 0, phenylbenzimidazole sulfonic acid, sulisobenzone and trolamine salicylate; the UVA absorbent sunscreen is selected from the group consisting of avobenzone and methyl anthranilate; and the physical blocker sunscreen is selected from the group consisting of titanium dioxide and zinc oxide and the cationic polymer is a polyquaternium. Some of these embodiments contain octyl methoxycinnamate, octocrylene, avobenzone, titanium dioxide and a polyquaternium selected from the group consisting of polyquaternium -A, -7, -11. -22, -27, -44, -51 or -64. A preferred polyquaternium is polyquaternium-4. Octyl methoxycinnamate can be encapsulated, e.g., in liquid colloid gel microcapsules. Octyl methoxycinnamate may be present in about 4.5-9% of octocrylene, octocrylene may be present in about 0.5-15%, avobenzone may be present in about 2-4% and titanium dioxide may be present in about 3-4%. 9% Additionally in embodiments containing pol? Quatern? O-4, pol? Quatern? O-4 may be present at about 0.5-3%. In some embodiments, octyl methoxycinnamate is present in about 7.6%, octocrylene is present in about 11.3%, avobenzone is present in about 2.8% and titanium dioxide is present in about 6.5%. Additionally in these embodiments containing pol? Quatern? O-4, pol? Quatern? O-4 may be present at about 2.8%. A film former, e.g., about 1.5% may also be present. In this aspect, the body bath claimed may also contain an active without sunscreen. In some modalities the active without sunscreen is selected from the group consisting of spheroidal anti-inflammatory active, analgesic, antifungal, antibacterial and antiparasitic active, anti-allergenic, medicinal assets, skin rash medications, skin disease and dermatitis, active insect repellents, antioxidants, hair growth promoter, hair bleaching agents, deodorant compounds and mixtures and combinations thereof. In some embodiments, at least one of the sunscreens is encapsulated, e.g., in microcapsules of liquid colloid gel. In some embodiments, the cationic polymer is a poly-temper In some modalities, the polyquaternium is poly-termaterm -4, -7, -11. -22, -27, -44, -51 or -64. In preferred embodiments, the cationic polymer is pol? Quatern? O-4. The embodiments may also contain a film former, a preservative and / or a stable antioxidant when exposed to sunlight. INCORPORATION BY REFERENCE All publications and patent applications mentioned in this specification are incorporated herein by reference to the same extent as if each individual patent application or publication was specifically and individually indicated by the reference. DETAILED DESCRIPTION OF THE INVENTION The present invention encompasses compositions containing one or more active ingredients (also referred to herein as "active") that can be added to a body bath composition to provide a combination of active / body bath. The invention also encompasses a body bath containing such an active ingredient. In some embodiments, the active ingredient is one or more sunscreens. The invention also encompasses methods for use and manufacture of the compositions and methods of commercialization. As used in the present "body bath" covers all cleaning vehicles applied to the body. The Exemplary forms of cleaning vehicles include, but are not limited to, liquid, stick, gel, foam, spray or spray pump, cream, lotion, stick, powder or incorporated in a patch or wipe. In addition, cleansers without soap can also be used. The body bath can be made in any suitable product form. Accordingly, as used herein, "body bath" includes, but is not limited to, a soap that includes liquid and bar soap; a shampoo; a hair conditioner; a bath gel; including an exfoliating bath gel; a foaming bath product (e.g., gel, soap or lotion); a milk bath; a soap-free cleanser, including a gel cleanser, a liquid cleanser and a cleansing bar; wet wipes; a body lotion; a dew, nebulization or body gel; effervescent bath tablets (e.g., bubble bath); a cream for hands and nails; a bath / shower gel; a cream for shower; a depilatory cream; a shaving product, e.g., a shaving cream, gel, foam or soap; a post-shave product, after-shave moisturizer and its combinations and any other composition used for body application for cleaning or after cleaning, including skin and hair. Soaps, e.g., liquid soaps and bar soaps and shampoos are especially useful as body baths in the invention.

I. Compositions In one aspect, the invention provides additives containing active ingredients, wherein the additive is designed to be added to a body wash (e.g., soap or shampoo). In some embodiments, the invention provides sunscreen compositions ("sunscreen additives") that can be added to a body bath preparation for imparting sun protection. In some embodiments, the invention provides a combination of a sunscreen additive and a body bath preparation ("sunscreen / body bath"). Accordingly, the sunscreen additive of the invention can be mixed with a conventional body bath; alternatively, the invention provides sunscreen / pre-mixed body bath. In any case, the sunscreen / body bath composition is generally applied in the same manner as the body bath alone and, typically, is rinsed with additive, e.g., sunscreen, which remains on the skin after rinsing. In some cases, e.g., cleansers without soap, the body bath is applied without rinsing. For sunscreen additives as part of a sunscreen / body bath, sun protection after application and, typically, rinsing, is on average greater than an SPF of 1, up to about an SPF 50. As used herein in the context of SPF, the "average SPF" is the SPF determined, as described herein, for about 5 to about 50 subjects, or about 5 to about 20 subjects, or about 5 to about 10 subjects, wherein the subjects preferably have skin. Type II. In some embodiments, the average SPF provided by the sunscreen / body bath after rinsing is from about 1 to about 50, or from about 2 to about 50, or from about 2 to about 40, or from about 2 to about 30, or from about 2 to about 20, or from about 2 to about 10, or from about 2 to about 5, or from about 5 to about 25, or from about 5 to about 20, or from about 5 to about 15, or from about about 5 to about 10. In some embodiments, the average SPF provided by the sunscreen / body bath after rinsing is above about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20. In some preferred embodiments, the average SPF after rinsing is above about 2. In some preferred embodiments, the SPF p Riddling after rinsing is above about 5. In some preferred embodiments, the SPF average after rinsing is above about 10. In some preferred embodiments, the average SPF after rinsing is above about 15. In some embodiments, the average SPF provided by the sunscreen / body bath of the invention remains above about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 for an average of at least about 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or more than about 10 hours after rinsing. In some embodiments, the average SPF provided by the sunscreen / body bath of the invention increases with each additional wash after a first wash, so that after a second, third, fourth, or fifth wash, the SPF provided can be found above about 2, 4, 6, 8, 10, 15, 20, 25, 30, 40, 45 or more than about 45. The SPF is a commonly used measure of photo protection of a sunscreen against erythema. This number is derived from another parameter, the minimum erythemal dose (MED). MED is defined as "the dose of least exposure at a specified wavelength that will emit a response to delayed erythema." The MED indicates the amount of energy that radiates from the skin and the ability of the skin to respond to radiation. The SPF of a particular protective photo is obtained by dividing the MED of the protected skin between the MED of the skin not protected. The greater the SPF, the more effective agent to prevent sunburn. The SPF value indicates how many more times a person can remain in the sun before the person experiences 1 MED. For example, the use of a sunscreen with an SPF of 6 will allow an individual to remain in the sun six more times before receiving 1 MED. As the SPF value of a sunscreen increases, there is a lower chance of developing a skin tan. Typically, commercially available sunscreen products have SPF values that range from about 2 to 45. Methods for measuring SPF are described e.g., in the FDA C.F.R. 21. A method for applying the sunscreen prior to the measurement is as follows: Wet 50 cm2 of the squared area of the test site with 10 ml of water supplied with a syringe. Apply the test sample according to the FDA Monograph to the area. Work the soap scum on the subject for 3 minutes to allow the product to be absorbed into the skin. Rinse the area after an additional 2 minutes with 20 ml of water. Dry with pats and allow 15 minutes before exposure to radiation according to the FDA Monograph. In some embodiments, after application of the body bath containing the additive (e.g., protective solar) to the skin followed by rinsing, the additive (e.g., sunscreen) penetrates an average of at least about 5 microns below the surface of the skin. In some embodiments, the additive penetrates an average of at least about 10, 15, 20, 25, 30, 40, 50, 60, 70, 80, 90, 100, 120 or 150 microns below the surface of the skin . In some embodiments, after application of the body bath containing the additive (eg, sunscreen) to the skin followed by rinsing, the additive (eg, sunscreen) penetrates an average of no more than 30 microns below the surface of the skin. In some embodiments, the additive penetrates an average of no more than about 50, 40, 30, 25, 20, 15, 10 or 5 microns below the surface of the skin. In some embodiments, after application of the body bath containing the additive (eg, sunscreen) to the skin followed by rinsing, the additive (eg, sunscreen) penetrates an average of about 5 to about 50, or about 5 to about 40, or from about 5 to about 30, or from about 10 to about 40, or from about 15 to about 40, or from about 20 to about 40, or about 5, 10, 15, 20, 25, 30, 25, 40, 45 or 50 microns below the surface of the skin. The depth of penetration can be tested by methods of dispossession of tape, as is well known in the art. The sunscreen additives and sunscreens / body baths of the invention contain at least one sunscreen. In some embodiments, the sunscreen additives of the invention contain one, two, three, four or more than four sunscreens. In preferred embodiments, the sunscreen additives of the invention include three sunscreens. In other preferred embodiments, the sunscreen additives of the invention include four sunscreens. Sunscreens can be organic or inorganic. Sunscreens may have a UVA absorber, a UVB absorber, a physical blocker, or any combination thereof. In some embodiments one or more of the sunscreens is encapsulated. A number of types of encapsulation may be employed as described herein. The compositions of the invention may include one or more non-sunscreen active ingredients, wherein the composition is designed to be an additive for a body bath. In some compositions of the invention, the active agents are provided in combination with one or more sunscreens. In some compositions, the active ingredients are provided without sunscreen. The additives, e.g., sunscreen additives and additives / body baths, e.g., sunscreen / bath body, of the invention may further include one or more components to provide a positive charge to the system to assist with binding to the protein and other charged components of the skin and / or hair, e.g., cationic polymeric agents. The cationic polymer can be, for example, a quaternary, e.g., polyquaternium. The additives, e.g., sunscreen additives and body additives / baths, e.g., sunscreen / body bath, of the invention may also include a film former. Other optional ingredients of the additives, eg, sunscreen additives and additives / body baths, eg, sunscreen / body bath, of the invention include preservatives, antioxidants, chelating agents, liquid hydrocarbon (eg, similar to pentane), foaming agents (eg, a cationic foaming agent), skin-nourishing, antibacterial, medicinal components and the like, as described below. The additives, e.g., sunscreen additives, of the invention can be combined with any conventional body bath. The body bath composition with which the additive, e.g., sunscreen additive is combined, can be any body bath known in the art or apparent to the person skilled in the art as described above. in modalities where the additive is a non-sunscreen additive, the additive can be combined with any composition intended for topical application. In these embodiments, the additive is frequently encapsulated, e.g., in liquid colloid gel microcapsules. In some embodiments, the invention provides an additive, e.g., sunscreen additive, in combination with a body bath composition, to provide an additive / body bath, e.g., sunscreen / body bath composition. In these embodiments, the additives, e.g., sunscreen additives, of the invention are provided in combination with one or more surfactants. The surfactant (s) may be cationic, ammonic, nonionic, zerotonic, amphoteric or any combination thereof. In preferred embodiments, the sunscreen / body bath compositions of the invention include at least one cationic surfactant. A. Sunscreens The sunscreen and sunscreen / body bath additives of the invention contain at least one sunscreen. The sunscreen can be organic or inorganic, or a combination of both can be used. Sunscreens for use in the invention include UV absorbers or blockers (e.g., many inorganic sunscreens are UV blockers). UV absorbers they can be a UVB or UVA absorber (e.g., UVA I or UVA II absorber). In some embodiments, the sun protection and sunscreen / body wash additives of the invention include an organic sunscreen and an inorganic sunscreen. In some embodiments, the sunscreen and sunscreen / body wash additives of the invention include more than one organic sunscreen (e.g., at least one UVB absorbent and at least one UVA absorber) and at least one inorganic sunscreen. In some embodiments, the sunscreen additives of the invention include only a physical blocker sunscreen, e.g., titanium dioxide. These embodiments may also contain a cationic polymer and / or a film former, as well as any other component described herein for sunscreen additive. Additional ingredients may include film formers, cationic polymers, antioxidants, preservatives and the like, as described herein. In some embodiments, the sunscreen or sunscreen / body bath additives of the invention include an organic sunscreen and an inorganic sunscreen. In some embodiments, the sunscreen or sunscreen / body wash additives of the invention include more than one organic sunscreen (e.g., at least one UVB absorbent and at least one UVA absorber) and at least one sunscreen inorganic In preferred embodiments, one or more of the sunscreens used in the invention are encapsulated. Any sunscreen known in the art or apparent to the skilled artisan can be used in the invention. The term "sunscreen" or "sunscreen agent" as used herein, defines ultraviolet ray blocking compounds that exhibit absorption or blockage within the wavelength region between about 290 and 420 nm. Sunscreens can be classified into five groups based on their chemical structure: para-amino benzoates; salicylates; cinnamates; benzophenones; and miscellaneous chemicals including menthyl antralinate and digaloyl trioleate. Inorganic sunscreens can also be used including titanium dioxide, zinc oxide, iron oxide and polymer particles such as polyethylene and polyamides. Suitable specific sunscreens include, for example: p-aminobenzoic acid, its salts and its derivatives (ethyl, isobutyl, glyceryl esters, p-dimethylaminobenzoic acid); anthranilates (α, ε, α-aminobenzoates, methyl, menthyl, phenyl, benzyl, phenylethyl, linalyl, terpinyl and cyclohexenyl esters); salicylates (amyl, phenyl, benzyl, menthyl, glyceryl and dipropylene glycol) esters); cinnamic acid derivatives (methyl and benzyl esters, alpha-phenyl cinnamonitopyl, butyl cinnamoyl pyruvate); dihydroxycinnamic acid derivatives (umbelliferone, methylumbelliferone, methylaceto-umbelliferone); derivatives of tphidroxicinamico acid (esculetin, metilesculetin, dafnetin and the glucosides, esculin and dafnin); hydrocarbons (difimylbutadiene, stilbene); dibenzalacetone and benzalacetophenone; naphthosulfonates (sodium salts of 2-naphthol-3, 3-d-sulfonic acid and 2-naphthol-6,8-d-sulfonic acid); dihydroxynaphthoic acid and its salts; o- and p-hydroxybiphenyldisulfonates; Coumarin derivatives (7-hydroxy, 7-methyl, 4-phenol); diazols (2-acetyl-3-bromoinsazole, phenyl benzoxazole, methyl naphthoxazole, various aryl benzothiazoles); quinine salts (bisulfate, sulfate, chloride, oleate and tannate); quinoline derivatives (8-hydroxyquinoline salts, 2-phenylquinoline); hydroxy or methoxy substituted benzophenones; unco and vilourico acids; tannic acid and its derivatives (e.g., hexaethylether); (butyl carbityl) (6-propyl piperonyl) ether; hydroquinone; benzophenones (oxibenzene, Sulisobenzone, dioxybenzone, benzoresorcinol, 2, 2 ', 4, 4' -tetrahydroxybenzophenone, 2,2'-d? h? drox? -4, 4 '-dimethoxybenzophenone, octabenzone, 4-? soprop? ld? benzoylmethane, butylmethoxydibenzoylmethane, ethacrylene, and 4-? soprop? ld? -benzoylmethane, titanium dioxide, iron oxide, zinc oxide and mixtures thereof. cosmetically acceptable and concentrations (percent by weight of the total cosmetic composition of sunscreen) include diethanolamine methoxycinnamate (10% or less), ethyl- [bis (hydroxypropyl)] aminobenzoate (5% or less), glyceryl aminobenzoate (3% or less), 4-? soprop? l dibenzoylmethane (5% or less), 4-met? lbenc? l? deno camphor (5% or less), terephthalidene dicamfor sulphonic acid (10% or less) and sulisobenzone (also called benzophenone) -, 10% or less). In preferred embodiments, sunscreens are approved by the FDA or approved for use in the European Union. For example, sunscreens approved by the FDA can be used alone or preferably in combination. See, e.g., the US Patents. Nos. 5,169,624; 5,543,136; 5,849,273; 5,904,917; 6,224,852; 6,217,852; and Segapn et al., Chapter VII, pages 189 of Cosmetics Science and Technology and Final Over-the-Counter Drug Products Monograph on Sunscreens (Federal Register, 1999: 64: 27666-27963), all of which are incorporated herein by reference. The reference . For example, for a product marketed in the United States, sunscreens and cosmetically acceptable concentrations (reported as a percentage by weight of the total cosmetic composition of sunscreen and referring to the final percentage of sunscreen after being added to the body bath) include: acid aminobenzoic acid (also called para-aminobenzoic acid and PABA, 15% or less, an organic UVB-absorbing sunscreen), avobenzone (also called butyl methoxy dibenzoylmethane, 3% or less, an organic UVA-absorbing sunscreen), cinoxate (also called 2-etox? et? l p-methoxycinnamate; 3% or less, an organic sunscreen absorber of UVB), dioxybenzone (also called benzophenone-8; 3% or less, an organic sunscreen absorber of UVA II), homosalate (15% or less, an organic UVB absorbent sunscreen), methyl anthranilate (also called menthol-2-aminophenzoate, 5% or less, an organic UVA II absorbent sunscreen), octocrylene (also called 2) -et? lhex? l-2-c? ano-3, 3-d? phenylacrylate, 10% or less, an organic sunscreen absorber of UVB), octyl methoxycinnamate (7.5% or less, an organic sunscreen absorber of UVB) ), octyl salicylate (also called 2-ethylhexyl salicylate; 5% or less, an organic sunscreen abs) UVB orbent), oxybenzone (also called benzophenone-3; 6% or less, an organic sunscreen absorber of UVB and UVA II), padimate O (also called octyl dimethyl PABA, 8% or less, an organic sunscreen absorber of UVB), phenylbenzimidazole sulfonic acid (water soluble; 4% or less, an organic sunscreen absorber of UVB), sulisobenzone (also called benzophenone-4, 10% or less, an organic sunscreen absorber of UVB and UVA II), dioxide titanium (25% or less, an inorganic UVA and UVB physical blocker), trolamine salicylate (also called triethanolamine salicylate, 12% or less, an organic UVB absorber) and zinc oxide (25% or less, UVA and UVB inorganic physical blocker). For a product marketed in the European Union, photoactive compounds and preferred cosmetically acceptable concentrations (reported as a percentage by weight of the total cosmetic composition of sunscreen and with reference to the final percentage of sunscreen after addition to the body bath) include: PABA (5% or less), camphor benzalkonium methosulphate (6% or less), homosalate (10% or less), benzophenone-3 (10% or less), fe-ilbenzimidazole sulfonic acid (8% or less, expressed as acid), terephthalic acid dicamfor sulfonic acid (10% or less, expressed as acid), butyl methoxydibenzoylmethane (5% or less), benzylidene camphor sulfonic acid (6% or less, expressed as acid), octocrylic (10% or less, expressed as acid), polyacrylamidomethyl benzylidene camphor (6% or less), octyl methoxycinnamate (10% or less), PEG-25 PABA (10% or less), isoamyl p-methoxymate (10% or less), ethylhexyl triazone (5% or less), dromethoxane trieloxane (15% or less), diethylhexyl butamido tpazone (10% or less), 4-met? Lbenc? L? Deno camphor (4% or less) ), 3-benzylidene camphor (2% or less), ethylhexyl salicylate (5% or less), ethylhexyl dimethyl PABA (8% or less), benzophenone-4 (5% expressed as acid), methylene bis-benztriazolyl tetramethylbutylphenol (10% or less), disodium phenyl dibenzimidazole tetrasulfonate (10% or less, expressed as acid) , bis-ethylhexyloxyphenol methoxyphenol tpazine (10% or less), methylene bisbenzotpazolyl tetramethylbutylphenol (10% or less, also called TINOSORB M) and bisethylhexyloxyphenol methoxyphenyl triazine (10% or less, also called TINOSORB) S) • In some embodiments, the sunscreen / sunscreen / body bath additives of the invention include a long chain silicone molecule with chromophores, eg, PARASOL SLX (DSM Nutptional Products), which contains benzyl malonate chromophores attached to specific points in a polysiloxane chain. Accordingly, in some embodiments, the invention provides a sunscreen additive or sunscreen / body bath composition containing a sunscreen comprising a long chain silicone molecule with chromophores. For example, the compositions of the invention include a composition containing octyl methoxycinnamate, octocplene, avobenzone, titanium dioxide and a long chain silicone molecule with chromophores. The long chain silicone molecule can be used in sunscreen additives in about 0.5 to about 5%, or in protectors solar / body baths in approximately 0.2 to approximately 2%. Inorganic UVA and UVB physical blockers useful in the invention further include iron oxide and polymer particles such as those of polyethylene and polyamides. In some embodiments, the sunscreen and sunscreen / body bath additives contain at least one sunscreen active which is cinnamate (eg, octylmethoxycinnamate (ethyl hexyl methoxycinnamate), (available under the tradename PARSOL MCX), oxybenzone (eg , benzophenone-3 (3-hydroxy-4-methoxybenzophenone), avobenzone (4-tert-butyl-4'-methoxybibenzoylmethane or PARSOL 1789), octyl salicylate (2-ethylhexyl salicylate), octocrylene (2-ethylhexyl-2-cyano- 3, 3-diphenylacrylate), methyl anthranilate and / or titanium dioxide or combinations thereof The sun protection and sunscreen / body wash additives of the invention, in some embodiments, may contain only dioxide as a sunscreen component. titanium When titanium dioxide is used in the compositions of the invention either alone or in combination with other sunscreens, titanium dioxide may have an anatase, rutile or amorphous structure. those of titanium dioxide can be uncoated or can be coated with a variety of materials including, but not limited to, aluminum compounds such as aluminum oxide, aluminum stearate, aluminum laurate and the like; phospholipids such as lecithin; silicone compounds; and its mixtures. Various grades and forms of titanium dioxide are described in the CTFA Cosmetic Ingredient Dictionary, Third Edition (1982), pp. 318-319; Pat. of E.U. No. 4,820,508 to Wortzman, issued April 11, 1989; and World Patent No. WO 90/11067 to Elsom et al., published October 4, 1990; These three references are incorporated by reference herein in their entirety. Titers of titanium dioxide suitable for use in the compositions of the present invention are commercially available such as the micronized MT series from Tp-K Industries (Emerson, NJ). These micronized titanium dioxides generally have a primary mean particle size that ranges from about 10 nm to about 50 nm. For example, titanium dioxide having a primary mean particle size of about 15 nm is available under the trade designations MT-150W (uncoated) and MT-100T (coated with stearic acid and aluminum compounds). Uncoated titanium dioxides having average primary particle sizes of about 35 nm and about 50 nm are available under the trade designations MT-500B and MT-600B, respectively.

Other coated titanium dioxides having a primary mean particle size around 15 nm include MT-100F (modified with stearic acid and iron hydroxide) and MT-100S (treated with lauric acid and aluminum hydroxide). Mixtures of two or more types and variations in particle size of titanium dioxide can be used in the present invention. A particularly preferred form of titanium dioxide is T? 02 coated with silica. Such T? 02 coated with silica is available under the tradename T-AVO (Eusolex). If a zinc compound is selected as the inorganic sunscreen, some zinc-based compositions (e.g., Z-Cote ™ HP1 [trademark, SkinCeuticals]) provide micro fine zinc oxide coated with a dimethicone form. As the manufacturer puts it, the dimethicone coating transforms the often granular and pasty zinc oxide particles into a smooth formulation that is transparent. The micronization of these particles achieves the important advantage of providing an effective solar protection without giving the appearance of a skin covered with white paint. They should also be noted in relation to the inorganic blockers, Tioveil and Spectraveil (both from the Tioxide Group). Tioveil includes products that are 40% Dispersions of titanium dioxide treated on the surface in a range of cosmetic vehicle. Spectraveil includes products that are 60% dispersions of zinc oxide in a range of cosmetic vehicle. In certain variations, these products may be film formers and may have advantageous uses herein. In sunscreen additives, total sunscreens comprise about 0.1-50%, or about 1-30%, or about 1-25%, or about 3-25%, or about 5-25%, or about 10-25. % or approximately 15-25%, or approximately 5, 10, 15, 20, 25, 30, 35, 40, 45 or 50% of the composition (all percentages herein are percentages by weight unless otherwise specified) opposite). In sunscreen / body bath compositions, total sunscreens may comprise 0.05-30% or about 0.5-15%, or about 0.5-12%, or about 1.5-12%, or about 2.5-12%, or about 5 to 12%. -12% or about 7-12%, or about 2.5, 5, 7.5, 10, 12-5, 15, 20, 25, 30, 33, 35, 40, 45, 50 or more than 50% of the composition. In some embodiments, a sunscreen additive of the invention includes octyl methoxymate at about 4.5-9%, octocrylene at about 0.5-15%, avobenzone (e.g., PARSOL 1789) at about 2-4% and titanium dioxide at approximately 3-9%. In some embodiments, octyl methoxycinnamate is encapsulated, e.g., in amorphous silica. Such encapsulated octyl methoxycinnamate is commercially available under the trade name of UV PEARLS; approximately 20-40% of UV PEARLS supplies approximately 4.5-9% octyl methoxycinnamate. In some embodiments, a sunscreen additive of the invention includes octyl methoxycinnamate at about 7.6% (in some embodiments, encapsulated as described, eg, in UV PEARLS, where UV PEARLS are provided at approximately 33.3%), octocrylene at about 11-3%, avobenzone (PARSOL 1789) at about 2.8% and titanium dioxide at about 6.4%. The sunscreen additives may also include a poly-ether, e.g., pol? Quatern? O-4. In some embodiments pol? Quatern? -4 is present from approximately 0.5% to approximately 5%, in some embodiments, polyquaternium-4 is present at approximately 2.8%. The sunscreen additives may further include a film former, which may comprise dimethicone and / or petroleum and / or a preservative, such as a BHT. This sunscreen additive can be added to a conventional body bath formulation (e.g., SOFT Body ash) in a ratio of approximately one part of the sunscreen additive to two parts of body bath (weight / weight). Other relationships are encompassed by the invention, eg, about one part of sunscreen additive at about 0.2, 0.5, 0.7, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 3.0, 3.2, 3.5, 3.7, 4.0, 4.2, 4.5, 4.7, 5.0, 6.0, 7.0, 8.0, 9.0, 10, 12, 15 or 20 parts of body bath (weight / weight). It will be appreciated by those skilled in the art that the various ingredients of the sunscreen additive may be added to the body bath all at once, or in groups, or separately. In some embodiments, the sun protection additive comprises at least two components. For example, the first component may comprise all ingredients except an inorganic sunscreen or physical blocker and the second component may comprise the inorganic sunscreen or physical blocker. The first component is added to the body bath with complete mixing, then the second component is added. For example, in some embodiments, all ingredients, except titanium dioxide, are mixed, then added to the body bath and then titanium dioxide is added (see Examples). In some embodiments, the sunscreen additives of the invention include about 0.1 to 7.5 percent by weight of octyl methyl cmamate, about 0.1 to 6 parts by weight of octyl salicylate, about 0.1 to 5 percent by weight of oxybenzone, about 1 to 10 percent by weight of cationic surfactant and about 0.01 to 1 percent by weight of a quaternized compound. These compositions may also include a film former. These compositions may also include 0.01 to 1 percent by weight of a condom. Encapsulation The sunscreens and other additives used in the invention can be encapsulated. One or more of the sunscreens used in a composition can be encapsulated; preferably, all the sunscreens used are encapsulated. Sunscreen assets can be encapsulated together, or they can be encapsulated separately, in any combination, in the same or different types of encapsulations. Generally, encapsulation involves trapping the sunscreen, e.g., in a vesicle. Depending on the selected vesicle, the gallbladder may rupture to open when applied. Without being limited by theories, it is believed that the vesicle breaks to open in various types of encapsulation due to friction, temperature, or pH of the skin or hair or some combination of these. By selecting the appropriate capsule and additives for the system, you can increase the stability, durability and / or SPF provided by the sunscreen additives and the sunscreen / body bath of the invention. Any encapsulation media known in the art can be used in the compositions of the invention, including, but not limited to, liposomes, maltodextrin capsules, silica gels, siloxanes and the like. A cationic or catanionic in the form of dry powder can also be used to encapsulate the sunscreen. Commercial embodiments of encapsulated sunscreens or vehicles suitable for encapsulating sunscreens include CATEZOMES (Engelhard Corp.), EUSOLEX UV PEARLS (EMD Biosciences) and others known in the art. Methods for encapsulation suitable for the delivery of beneficial agents that are mixed with a body bath composition are well known in the art. See, e.g., US Patents. Nos. 6,825,161; 6,436,375; 6,238,650 6,468,509, 6,362,146; 6,074,630; 5,455,048; 5,770,556 5,955,409; 5,876,755; 4,803,195; 5,508,259; 4,479,501 6,248,703; 5,476,660; and 4,904,524 and Patents of EP Nos. 0,254,447; 0.025.379; and 0.399.911. A particularly preferred encapsulation method is liquid gel colloid encapsulation. This technique is described, e.g., in the US Patents. Nos. 6,238,650; 6,436,375; 6,303,149; and 6,468,509. Any or all of the sunscreens and / or active ingredients of the compositions of the invention can be encapsulated by of such encapsulation in liquid colloid gel. The liquid colloid gel capsules can be prepared in order to have a surface charge, e.g., a cationic charge. This is advantageous since otherwise the water-insoluble components can be encapsulated within the microcapsules, which are then freely miscible in water, e.g., without the need for an emulsifying agent. For example, in some embodiments, a UVA absorber, a UVB absorber (eg, octyl methoxycinnamate) and / or a physical blocker, eg, titanium dioxide, is provided as a liquid colloid silica gel encapsulate, optionally with additional ingredients which include PVP. chlorphenesin and an antioxidant such as BHT. A commercial embodiment of such encapsulation containing octyl methoxycinnamate, PVP, chlorphenesin and BHT, is available under the trade name EUSOLEX UV PEARLS (EMD Biosciences). Such an encapsulated UVB absorber of liquid colloid silica gel, eg, octyl methoxymate, can be used in a sunscreen additive at a concentration that results in a final concentration of the UVB absorber of about 1% to about 40%, or about 2% to about 20%, or from about 2% to about 10%, or from about 5% to about 10%, or about 6%, 7%, 7.4%, 7.5%, 7.6%, 8% or 9% . The preferred final concentration is about 7.6%. in other modalities, more than one sunscreen is encapsulated as a liquid colloid silica gel encapsulate. In these embodiments, the final concentration of each sunscreen, independently, in the final sunscreen additive, is from about 1% to about 40%, or from about 2% to about 20%, or from about 2% to about 10%. %, or approximately 1%, 2%, 3%, 4%, 5%, 6%, 7%, 7.5%, 8%, 9% or 10%. Sunscreens can be encapsulated together or separately or in any combination thereof. In some embodiments, the invention provides an additive to be added to a body bath that includes a sunscreen encapsulated in a sol-gel microcapsule and a cationic polymer (described below). Additional ingredients in these embodiments may include a film former, antioxidant, preservative, chelating agent, thickener, emollient and / or other active and inactive ingredients as described herein. In some embodiments where encapsulation is used, eg microencapsulation in liquid colloid gel, the composition of the microcapsule, eg, a sol-gel microcapsule, may vary in order to allow variable amounts of the active, eg, sunscreen, inside the microcapsule, which is going to be released. The microcapsules, e.g., microcapsules of liquid colloid gel, they can be prepared in order to experience none or a minimum breakage when applied to the skin and left on the skin. Alternatively, the microcapsules, e.g., liquid colloid gel microcapsules, can be prepared in order to undergo various degrees of breakage, on average, when applied to the skin and left on the skin. Accordingly, the microcapsules, eg, liquid colloid gel microcapsules, can be prepared in order to undergo a break of about 0%, or a break in a range of about 0.1, 0.5, 1, 2, 5, 10, 20, 30, 40, 50, 60, 70, 80, or 90% at about 0.5, 1, 2, 5, 10, 20, 30, 40, 50, 60, 70, 80, or 90% after application (or of the application and rinse in the case of a body bath containing the microcapsules). In addition, the microcapsules can be formulated in order to break open in response to conditions that occur in the skin, so that after application, the microcapsules act to release their contents in a time-controlled or controlled manner. The exemplary non-limiting conditions of the skin or hair that can vary with the user's environment, which variation can activate the breakdown of the microcapsules, include pH, temperature, friction, exposure to light or air, pressure and the like. Other forms of immobilization or entrapment of the sunscreen and other active components are also useful.

For example, as a further variant of the use of chemical sunscreen agents, the compositions of the invention may employ an organic sunscreen such as octyl methoxycinnamate entrapped within a matrix. A commercial example of such a composition is found in SunCaps ™ (trademark, SkinCeuticals) in which the organic sunscreen molecules are uniformly distributed throughout the particle. B. Non-Sunscreen Assets In one aspect, the invention provides additives containing non-sunscreen active ingredients, wherein the additive is designed to be added to a composition for topical application, e.g., a body bath. These active ingredients can be used in combination with the above-described sunscreens in a sunscreen additive or sunscreen / body bath, or can be used in separate compositions, not sunscreen. In some modalities, at least one of the assets is encapsulated. In another aspect, the invention provides a composition for topical application, e.g., a body bath, containing one or more such active agents. These active ingredients can be used in combination with the above-described sunscreens in a sunscreen or sunscreen / body bath additive, or they can be used in separate compositions, not sunscreen.

Non-limiting examples of non-sunscreen active ingredients useful in the compositions of the invention include sunless tanning actives, skin rinse actives, anti-acne actives, anti-wrinkle and skin anti-aging actives, vitamins, active ingredients. anti-inflammatory, active anesthetics, analgesic active, anti-pruritus active, anti-microbial active (eg, antifungal, antibacterial and antiparasitic), antiviral, antialergenic, active medicinal (eg, medications for skin rash, skin disease and dermatitis ), anti-cellulite additives, active insect repellents, antioxidants, hair growth promoters, hair growth inhibitors, hair bleaching agents, deodorant compounds and mixtures and combinations thereof. Sunless tanning actives include dihydroxyacetone (DHA), glyceryl aldehyde; tyrosine and tyrosine derivatives such as mallytyrosine, tyrosine glucosinate and ethyl tyrosma; phospho-DOPA, indols and derivatives; and its mixtures. Non-limiting examples of skin rinse actives include AMBLICA (also an antioxidant), monobenzone (a depigmentation agent), kojic acid, arbutin, ascorbic acid and its derivatives (e.g., magnesium ascorbyl phosphate or sodium ascorbyl phosphate) and extracts (e.g., extract of varbasco, placenta extract). Non-limiting examples of Skin lightening agents suitable for use herein also include those described in WO 95/34280, WO 95/07432 and WO 95/23780. Vitamins may be included in the compositions of the present invention. Examples include vitamin A and its derivatives (including, for example, retinol, see, active anti-wrinkle), ascorbic acid (vitamin C and its derivatives), vitamin B (eg, riboflavin, vitamin B2), biotin, vitamin D ( all forms), vitamin E and its derivatives such as tocofepl acetate, beta carotene, pantothenic acid and mixtures thereof. Anti-acne derivatives include benzoyl peroxide, epromycin, clindamycin phosphate, 5,7-d-chloro-8-hydroxyquinoline, resorcinol, resorcinol acetate, salicylic acid, azaleic acid, long chain dicarboxylic acids, sulfur, zinc, various natural agents such as the green tree derivatives and their mixtures. Other non-limiting examples of anti-acne active ingredients suitable for use herein are described in US Pat. of E.U. No. 5,607,980, the disclosure of which is incorporated herein by reference. Anti-wrinkle assets include a variety of agents, often in combination, that prevent or treat wrinkles through a variety of actions. Many procedures are taken to reduce the appearance of facial wrinkles based on the understanding of the base Molecular structure of wrinkles. Such treatments include cosmetic products, drug therapy and surgical procedures. For example, many cosmetic products contain hydroxy acids that can stimulate the synthesis of collagen. Another common treatment uses retinol, retinoic acid, retinol palmitate, a derivative of vitamin A (or its prescribed version stronger retin-A and Renova) that help the production of collagen. Bicyclic aromatic compounds with retinoid-like activity, useful in particular for preventing or treating various keratinization disorders, are described in EP 679 630. These compounds are particularly active in repairing or combating the chronological or actinic aging of the skin, for example, as in the anti-wrinkle products. It is believed that antioxidants such as vitamin C and E and coenzyme Q-10 counteract free radicals that damage cells and cause aging and have been used in wrinkle treatments. Recently, the FDA approved the cosmetic use of botox (an extremely diluted form of botulinum toxin) to treat fine lines. Accordingly, the non-sunscreen active ingredients of the invention which are anti-aging or anti-wrinkle active can contain, alone or in combination, the aforementioned bicyclic aromatic compounds, other compounds having retinoid-like activity, free radical scavengers, hydroxy acids or keto or their derivatives. The term "free radical scavenger" refers, for example, to α-tocopherol, superoxide dismutase, ubiquinol or certain metal chelating agents. Hydroxy acids include, e.g., alpha hydroxy acids such as lactic acid and glycolic acid or beta hydroxy acids such as salicylic acid and salicylic acid derivatives such as the octanoyl derivative; Other hydroxy acids and keto acids include malic, citric, mandelic, tartaric or glyceric acid or the salts, amides or esters thereof. Other anti-wrinkle and anti-aging agents useful in the invention include amino acids D and L containing sulfur and its derivatives and salts, particularly, the N-acetyl derivatives, of which a preferred example is N-acetyl-L-cysteine; thiols, e.g., ethane thiol; fat-soluble vitamins, ascorbyl palmitate, ceramides, pseudoceramides (eg, the pseudoceramides described in US Patents Nos. 5,198,210; 4,778,823; 4,985,547; 5,175,321, all of which are incorporated by reference herein), phospholipids (eg, distearoil lecithin phospholipid), fatty acids, fatty alcohols, cholesterol, plant sterols, phytic acid, lipoic acid; lysophosphatidic acid and skin peeling agents (e.g., phenol and the like) and mixtures thereof. Preferred fatty acids or alcohols are those that have chains straight or branched alkyl containing 12-20 carbon atoms. A particularly preferred fatty acid is linoleic acid because linoleic acid aids in the absorption of ultraviolet light and is also a vital component of the skin's natural lipids. Other non-limiting examples of anti-wrinkle active suitable for use herein are described in the U.S. Patent. No. 6,217,888, the disclosure of which is incorporated herein by reference. Anti-inflammatory assets include spheroidal, nonsteroidal and other compounds. Non-limiting examples of anti-inflammatory steroidal agents suitable for use herein include corticosteroids such as hydrocortisone, hydroxyvitrazinone, alpha-methyl dexamethasone, dexamethasone-phosphate, beclomethasone dipropionates, clobetasol valerate, desonide, deoxymethasone, deoxycorticosterone acetate, dexamethasone, dichlorisome, diflorasone diacetate, valerate diflucortolone, fluadrenolone, fluclorolone acetonide, fludrocortisone, flumethasone pivalate, fluosinolone acetonide, fluocinonide, flucortine butylesters, fluocortolone, fluprednidene (fluprednylidene) acetate, flurandrenolone, halcinonide, hydrocortisone acetate, hydrocortisone butyrate, methylprednisolone, tpamcinolona acetonide, cortisone, cortodoxone , fluacetonide, fludrocortisone, difluorosone diacetate, fluradrenolone, fludrocortisone, difluorosone diacetate, fluradrenolone acetonide, medrisone, amcinafel, amcinafide, betamethasone and the balance of their esters, chloroprednisone, chlorprednisone acetate, clocortelone, clescinolone, diclopsone, difluprednate, flucloronide, flunisolide, fluorometalone, fluperolone, fluprednisolone, hydrocortisone valerate, hydrocortisone cyclopentylpropionate, hydrocortamate, meprednisone, parametasone, prednisolone, prednisone, beclomethasone dipropionate, triamcinolone and mixtures thereof. The preferred steroidal anti-inflammatory agent for its use is hydrocortisone. Non-steroidal anti-inflammatory agents are also useful for use herein as skin active agents in the compositions of the invention. Non-limiting examples of non-spheroidal anti-inflammatory agents suitable for use herein include oxicams (e.g., piroxicam, isoxicam, tenoxicam, sudoxicam, CP-14,304); salicylates (e.g., aspirin, disalcid, benorilate, tpllisate, safaprin, solppn, diflunisal, fendosal); acetic acid derivatives (e.g., dielofenac, fenclofenac, indomethacin, sulindac, tolmetin, isoxepac, furofenac, thiopinac, zidomethacin, acematacin, fentiazac, zomepirac, clindanaco, oxepinaco, felbinaco, ketorolac); fenamates (e.g., mefenamic, meclofenamic, flufenamic, niflumic, telfenamic acids); propionic acid derivatives (e.g., ibuprofen, naproxen, benoxaprofen, flurbiprofen, ketoprofen, fenoprofen, fenbufen, midoprophenone, pirprofen, carprofen, oxaprozm, pranoprofen, miroprofen, thioxaprofen, suprofen, almmoprofen, tiarophenic); pyrazoloids (e.g., phenylbutazone, oxyphenbutazone, feprazone, azapropazone, trimetazone); and combinations thereof, as well as any dermatologically acceptable salt or ester thereof. COX-2 inhibitors are also suitable for use herein, and include, but are not limited to, AZD 3582 (ASTRAZENECA and NicOx), Celecoxib (PHARMACIA Corp.) (4- [5- (4-met? Lfen? L) -3- (tnfluoromethyl) -lH-p? Razol-1-? L] benzenesulfonamide), Meloxicam (BOEHRINGER INGELHEIM Pharmaceuticals) (4-h? Drox? - 2-met? N- (5-met? L-2-t? Azol? L) -2H-1, 2GW-406381 (GLAXOSMITHKLINE), Etoxicoxib (MERCK &Co.), Rofecoxib (MERCK &Co.) (4- [4- (Methylsulfonyl) phenyl] -3-phenyl-2 (5H) -furanone), Lumiracoxib (NOVARTIS Pharma AG), Valdecoxib (PHARMACIA Corp.) (4- (5-met? L-3-phen ? l-4-? sox-azole?) benzenesulfonamide) and Etodolac (WYETH Ayerst Laboratories) (acid (. + -.) 1, 8-d? et? ll, 3, 4, 9-tetrah? drop? rano - [3, -b]) Other non-limiting examples of suitable anti-inflammatory agents or other active ingredients in the skin include candelilla wax, bisabolol (eg, alpha bisabolol), aloe vera, plant sterols (eg, phytosterol), manjustha (extracted of plants in the genus Rubia, particularly Rubia Cordifolia) and Guggal (extracted from plants in the genus Commiphora, particularly Commiphora Mukul), extract of cola, chamomile, extract of red clover, seaweed extract, anise oil, garlic oil , ginger extract, vasoconstrictors such as phenylephrine hydrochloride and combinations thereof. Further non-limiting examples of suitable anti-inflammatory agents or other active ingredients in the skin include components of the Licopce family (the genus / plant species Glycyrrhiza glabra), including glycyrrhizic acid, glycyrrhizic acid and its derivatives (e.g., salts and esters). Suitable salts of the above compounds include metal salts and ammonia. Suitable esters include saturated and unsaturated C2_C24 esters of the acids, preferably C? Or C24, more preferably C? 6-C24. Specific non-limiting examples of the above include oil-soluble liquorice extract, glycyrrhizic and glycyrrheic acid itself, monoammonium glycyrrhizinate, monopotassium glycyrrhizinate, dipotassium glycyrrhizinate, 1-beta-glycyrrhenetic acid, stearyl glycyrheinate and 3-stearate-glycyrhetinic acid, disodium 3-succ? N? Lox? -beta-glycyrrhetinate and combinations thereof. Active anesthetics include butamben picrate, lidocaine, xylocaine, benzocaine, bupivacaine, chlorprocaine, dibucaine, etidocaine, mepivacaine, tetracaine, dyclonine, hexylcaine, procaine, cocaine, ketamine, pramoxin, phenol and pharmaceutically acceptable salts thereof. Analgesic active ingredients include diclofin hydrochloride, aloe vera, fentanyl, capsaicin and the like. Anti-pruritic actives include alclometasone dipropionate, betamethasone valerate, and isopropyl miptate MSD. Anti-microbial active ingredients include anti-fungal, antibacterial and antiseptic compounds. Anti-fungal compounds include, but are not limited to, compounds such as anti-fungal mithozole. Specific anti-fungi include butocouazole nitrate, miconazole, econazolo, ketoconazole, oxiconazole, haloprogin, clotrimazole and butenafine HCl, naftifine, terbinafma, cyclopirox and tolnaftate. Antibacterial and antiseptic compounds include phenol-TEA complex, mupirocin, triclosan, chlorocresol, chlorbutol iodine, clindamycin, CAE (An inomoto Co., Inc., containing DL-pyrrolidone carboxylic acid salt of L-cocoyl arginine ethyl ester), povidone-iodine, polymixin b sulfate-bacitracin, zmc-neomycin sulfate-hydrocortisone, chloramphenicol, methylbenzethonium chloride and erythromycin and antiseptics (eg, benzalkonium chloride, benzethonium chloride, chlorhexidine gluconate, mafenide acetate, nitrofurazone, nitromersol and the like can be included in the compositions of the invention. Many deodorant compounds are also antimicrobial (see below). Anti-parasitics such as lindane may also be included. Additional examples of antimicrobial and anti-fungal actives useful in the compositions of the present invention, include, but are not limited to, b-lactam drugs, quinolone drugs, ciprofloxacm, norfloxacin, tetracycline, amicaein, 2, 4, 4 '- tr? chlor-2 '-hydroxy diphenyl ether, 3,4,4'-tpchlorocarbanilide, phenoxyethanol, phenoxypropanol, phenoxanopropanol, doxycycline, capreomycin, chlorhexidine, chlortetracycline, oxytetracycline, ethambutol, hexamidine isothionate, metronidazole, pentamidine, gentamicin, kanamycin, lineomycin , metacycline, methenamine, minocycline, neomycin, netilmicin, paromycin, streptomycin, tobramicma, miconazole, tetracycline, hydrochloride, eptromicma, zinc eptromycin, erythromycin estolate, epigomycin stearate, amikacin sulfate, doxycycline hydrochloride,. Capreomycin sulfate, chlorhexidine gluconate, chlorhexidine hydrochloride, chlortetracycline hydrochloride, oxytetracycline hydrochloride, clindamycin hydrochloride, ethambutol hydrochloride, metronidazole hydrochloride, pentamidine hydrochloride, gentamicin sulfate, kanamycin sulfate, lineomycin hydrochloride, methacycline hydrochloride, methenamine hippurate, methenamma mandelate, minocycline hydrochloride, neomycin sulfate , methylmycin sulfate, paromycin sulfate, streptomycin sulfate, tobramycin sulfate, miconazole hydrochloride, amanfadine hydrochloride, amanfadine sulfate, octopirox, parachlorometa xylenol, nystatin, tolnaftate, zinc pipthiona and clotpmazol. The compositions of the invention may include antiviral agents. Suitable antiviral agents include, but are not limited to, metal salts (eg, silver nitrate, copper sulfate, iron chloride, etc.) and organic acids (eg, malic acid, salicylic acid, succinic acid, benzoic acid). , etc.). In particular compositions containing additional suitable antiviral agents, those described in the U.S. patent applications are included. co-pending Ser. Nos. 09 / 421,084 (Beerse et al); 09 / 421,131 (Bidermann et al); 09 / 420,646 (Morgan et al); and 09 / 421,179 (Page et al), which were each filed on October 19, 1999. Anti-allergens include antihistamines. Antihistamines can be Hi or H2 antagonists or other types of histamine release inhibitors. Antagonists Hi can be sedative or non-sedating. Examples of sedating Hx antihistamines include diphenylhydramma (Benadpl), chlorpheniramine, tripelenamine, promethazine, clemastine, doxilamma, benadry etc. Examples of non-sedating antihistamines Hi include astemizole, terfenadine, loratadine etc. Examples of H2 antagonists include cymetadine, famotadine, nizatidine and ranitidine. Examples of histamine release inhibitors include cromolyn. An additional active useful in the invention may be a medicinal for the treatment of dermatological conditions such as psoriasis, acne, eczema and other skin conditions due to disease, pathology, accident and the like. Medicaments include ointments for the relief of burns, such as o-amino-p-toluenesulfonamide monoacetate; dermatitis relief agents such as the active steroid amcinonide, diflorasone diacetate, and hydrocortisone; diaper rash relief agents such as methylbenzethionium chloride and the like; drugs for the treatment of herpes, such as 0- [2-h? drox? etox? ) methyl] guanine; psoriasis, seborrhoea and scabies agents such as slate oil and its derivatives, elubiol, ketoconazole, coal tar and petroleum distillates, salicylic acid, zinc pyrithione, selenium sulfur, hydrocortisone, sulfur, menthol, psoralen, pramoxine hydrochloride antralin and methoxsalen; spheroids such as 2- (acetyloxy) -9-fluoro-1 ', 2', 3 ', 4'-tetrahydro-11-hydrox-pregna-1,4-dino [16, 17-b] ] naphthalene-3, 20-d-one and 21-chloro-9-fluoro-1 ', 2', 3 '.4'-tetrahydro-llb-h? drox? pregna-l, 4-d? ene [16z, 17-b] naphthalene-3, 20-d ?one and others including those that are anti-inflammatory. Other medicines include those useful in the treatment of exposure to poison oak, poison ivy, poisonous sumac and the like. These include camphor, menthol, benzocaine, butamben picrate, dibucaine, dibucaine hydrochloride, dimetisoquine hydrochloride, dyclonine hydrochloride, lidocaine, metacresol, lidocame hydrochloride, pramoxine hydrochloride, tetracaine, tetracaine hydrochloride, benzyl alcohol, camphor metacresol, juniper tar, phenol, phenolate sodium, resorcinol, diphenhydramine hydrochloride, tppelenamine hydrochloride, hydrocortisone, a corticosteroid, and hydrocortisone acetate. Any other medication capable of topical administration may also be incorporated in a composition of the present invention in an amount sufficient to carry out its intended function. Anti-cellulite active ingredients include isobutylmethylxanthine, caffeine, theophylline, theobromine, yohimbine aminophyll and mixtures thereof. Examples of suitable actives for treating hair loss include, but are not limited to, potassium channel openers or peripheral vasodilators such as mmoxidil, diazoxide and compounds such as N * -c-ano-N- (ter-pentyl) - N '-3-p? Pd? N? L-guan? D? Na ("P-1075") as described in the US Pat. No. 5,244,664, which is incorporated herein by reference; vitamins, such as vitamin E and vitamin C and derivatives thereof such as acetate vitamin E and vitamin C palmitate; hormones, such as erythropoieme, prostaglandins, such as prostaglandin El and prostaglandin F2-alpha; fatty acids, such as oleic acid; diuretics such as spironolactone; heat shock proteins ("HSP") such as HSP 27 and HSP 72; calcium channel blockers, such as verapamil HCL, nifedipine and diltiazemamilopda; immunosuppressive drugs such as ciclospopn and Fk-506; 5 alpha-reductase inhibitors such as finastepda; growth factors such as EGF, IGF and FGF; beta factor of transformation growth; tumor necrosis factor; non-spheroidal anti-inflammatory agents, such as benoxaprofen; retmoids such as tretinoin; cytosomes such as IL-6, IL-1 alpha, and IL-1 beta; cell adhesion molecules such as ICAM; glucocorticoids such as betamethasone; botanical extracts such as aloe, clove, ginseng, rehmania, swertia, sweet orange, zanoxilum, Serenoa repens (palmito sierra), Hypoxis rooperi, spicy stinging nettle, pumpkin seeds and rye pollen; other botanical extracts including sandalwood, beet root, chrysanthemum, rosemary, burdock root and other hair growth promoting activators which are described in DE 4330597 which is incorporated by reference in its entirety herein; homeopathic agents such as Kalium Phosphopcum D2, azadirachta indicates D2 and Joborandi DI; genes for cytosomes, growth factors and baldness; anti-fungi such as ketoconazole and elubiol; antibiotics such as streptomycin; protein inhibitors such as cycloheximide; acetazolamide; benoxaprofen; cortisone; diltiazem; hexachlorobenzene; hindantoin; nifedipine; penicillamine; phenotaiazines; pinacidil; psoralens, verapamil; zidovudine; alpha-glycosylated routine having at least one of the following routines: quercetin, isoquercitrin, hespedin, napngin and methylhesperidin and flavonoids and their transglycosylated derivatives which are all described in JP 7002677 which is incorporated by reference herein in its entirety; and mixtures thereof. Preferred agents for the treatment of hair loss include minoxidil, 6- (Ip? Pepd? N? L) -2, 4-p? R? M? D? Nad? Am? Na-3-oxide, N'-cyano-N- (ter-pentyl) -N'-3-p? Pd? N? L-guan? D? Na, finastepda, retinoids and their derivatives, ketoconazole, elubiol or their mixtures. Examples of suitable actives for use in the inhibition of hair growth include: serine proteases such as trypsin; vitamins such as alpha-tocopherol (vitamin E) and its derivatives such as tocopherol acetate and tocopherol palmitate; antineoplastic agents, such as doxorubicin, cyclophosphamide, chlormetin, methotrexate, fluorouracil, vincpstine, daunorubicin, bleomycin and hydroxycarbamide; anticoagulants such as hepapna, heparinoids, coumapinas, dextran and indandiones; antithyroid drugs such as iodine, thiouracils and carbimazolo; lithium and lithium carbonate; interferons such as interferon alfa, inferred alpha-2a and inferred alpha-2b; retinoids such as retinol (vitamin A), isotretmoma; glucocorticoids such as betamethasone and dexamethasone; antihyperlipidemic drugs such as triparanol and clofibrate; thallium; mercury; albendazolo; alopupnol; amiodarone; amphetamines; androgens; bromocpptine; butyrophenones; carbamazepine; cholestyramine; cimetidine; clofibrate; Danazol; desipramine; dixirazine; Ethambutol; ethionamide; fluoxetine; gentamicin, gold salts; hydatid ibuprofen; impramine immunoglobulins; indandiones; indomethacin; intraconazole; levadopa; maprotilma; methysergide; metoprolol; metyrapone; nadolol; nicotinic acid; potassium thiocyanate; propranolol; pyridoestimine; salicylates; sulfasalazine; terfenadine; thiamphenicol; thiouracils; trimethadione; troparanol; valproic acid; and its mixtures. Preferred hair growth agents include serine proteases, retinol, isotretinoin, betamethoisone, alpha tocopherol and their derivatives or mixtures thereof. Examples of hair bleaching agents include perborate or persulfate salts. Deodorant compounds include salts astringents and bioactive compounds. The astringent salts include organic and inorganic salts of aluminum, zirconium, zinc and mixtures thereof. The anion of the astringent salt may be, for example, sulfate, chloride, chlorohydroxide, alum, formate, lactate, benzyl sulfonate, or phenyl sulfonate. Exemplary classes of antiperspirant astringent salts include aluminum halides, aluminum hydroxyhalides, zirconyl oxyhalides, zirconyl hydroxyhalides and mixtures thereof. Exemplary aluminum salts include aluminum chloride and aluminum hydroxyhalides having the general formula Al2 (OH) xQ and XH20, wherein Q is chlorine, bromine or iodine; x is from about 2 to about 5; x + y is approximately 6, where x and y are not necessarily integers; and X is from about 1 to about 6. Exemplary zirconium compounds include zirconium oxy salts and zirconium hydroxy salts, also referred to as zirconyl salts and hydroxy zirconyl salts and represented by the general empirical formula Zr0 (0H) 2- nz Lz, where z varies from about 0.9 to about 2 and is not necessarily an integer; n is the valence of L; 2-nz is greater than or equal to 0; and L is selected from the group consisting of halides, nitrate, sulfamate, sulfate and mixtures thereof. Accordingly, exemplary deodorant compounds include, but are not limited to, aluminum bromohydrate, potassium alum, sodium aluminum chlorohydroxy lactate, aluminum sulfate, aluminum chlorohydrate, aluminum-zirconium tetrachlorohydrate, an aluminum-zirconium polychlorohydrate complexed with glycine, aluminum-zirconium tpclorohydrate, aluminum-zirconium octachlorohydrate, aluminum sesquichlorohydrate, aluminum sesquichlorohydrex PG, aluminum chlorohydrex PEG , aluminum zirconium octachlorohydrex glycine complex, aluminum zirconium pentachlorohydrex glycine complex, aluminum zirconium tetrachlorohydrex glycine complex, aluminum zirconium tpchlorohydrex glycine complex, aluminum chlorohydrex PG, zirconium chlorohydrate, aluminum dichlorohydrate, aluminum dichlorohydrex PEG, aluminum dichlorohydrex PG, aluminum sesquichlorohydrex PG, aluminum chloride, aluminum zirconium pentachlorohydrate, numerous other useful antiperspirant compounds listed in the CTFA Handbook on page 56, incorporated herein by reference and mixtures thereof. In addition to the astringent salts, the deodorant compound can be a quaternary ammonium bacte-ppostatic compound, such as, for example, cetyl trimethyl ammonium bromide, cetyl pyridinium chloride, benzethonium chloride, dnsobutilbenzoxyethoxyethyldimethylbenzyl ammonium chloride, sodium N-laupl sarcosm, sodium N-polymethyl sarcosma, lauroyl sarcosma, N-myristoyl glycine, potassium N-lauroyl sarcosm and stearyl ammonium chloride; or a bioactive compound; or one carbonate or bicarbonate salt, such as, for example, the alkali metal carbonates and bicarbonates and the carbonates and bicarbonates of ammonium and tetralkylammonium. Other useful deodorizing compounds include chlorophyllin copper complex, aluminum chloride, aluminum chloride hexahydrate and methylbenvonthonium chloride. Antioxidants are also useful in the formulations of the invention. Typical suitable antioxidants include propyl, octyl and dodecyl esters of gallic acid, butylated hydroxyanisole (BHA, commonly purchased as a mixture of ortho and meta-isomers), butylated hydroxytoluene (BHT), nordhydroguaiaretic acid, vitamin A, ascorbic acid and its salts, ascorbyl fatty acid esters, ascorbic acid derivatives (eg, magnesium ascorbyl phosphate, sodium ascorbyl phosphate, ascorbyl sorbate), tocopherol, tocopherol acetate, other tocopherol esters, tocotrienols and their esters and 6-hydrox-2 acid, 5, 7, 8-tetramethyl-lchroman-2-carboxylic (commercially available under the tradename TROLOX). Other suitable antioxidants include unco acid and its salts and alkyl esters, sorbic acid and its salts, lipoic acid, amines (eg, N, N-diethylhydroxylamine, amino guanidine), sulfhydryl compounds (eg, glutathione, N-acetyl cistern), fumaric dihydroxy acid and its salts, licina pidolato, arginine pilolate, nordihydroguaiaretico acid, bioflavonoids, curcumin, Lysine, methionine, proline, superoxide dismutase, silmapn, tea extracts, skin / grapeseed extracts, melanin and rosemary extracts can be used. The preferred antioxidants are photostable antioxidants. A photo-stable antioxidant is marketed under the trade name EMBLICA by EMD Chemicals. See, e.g., US Patent. No. 6,831,191. Antioxidants, preferably photostable antioxidants (eg, EMBLICA), may be included in sunscreen additives at about 0.05 to about 5% or at about 0.05 to about 2%, or at about 0.1%, 0.2%, 0.3% or 0.4% or on protectants solar / body baths at about 0.02 to about 2%, or at about 0.02 to about 1%, or at about 0.04%, 0.06%, 0.08%, 0.1%, 0.2%, or 0.3%. Insect repellents include the most widely used active agent for personal care products, N, N-diethyl-m-toluamide, often called "DEET" and available in the form of a concentrate containing at least about 95 percent DEET. Other synthetic chemical repellents include dimethyl phthalate, ethyl hexanediol, indalone, di-n-propylisocincoronate, bicycloheptene, dicarboximide and tetrahydrofuraldehyde. Certain plant-derived materials also have insect repellent activity, including citrus and other sources of citrus (including lemon leaf oil), lemon, rosemary oil and eucalyptus oil. The selection of an insect repellent for incorporation into the compositions of the invention will often be influenced by the smell of the repellent. The amount of the repellent agent used will depend on the selection of the agent; DEET is useful at high concentrations such as up to about 15 percent or more, while some of the plant-derived substances are typically used in much lower amounts such as 0.1 percent or less. The compositions of the present invention may contain a wide range of additional active components. The CTFA Cosmetic Ingredient Handbook, Seventh Edition, 1997 and Eighth Edition 2000, which is incorporated by reference herein in its entirety, discloses a wide variety of active ingredients commonly used in skin care compositions that are suitable for use in the compositions of the present invention. Other topically active compounds are listed in Remington's Pharmaceutical Sciences, 20th edition, Lippincott Williams & Witkins, Baltimore, MD (2000) (hereinafter Remmgton's), U.S. Pharmacopoeia and National Formulary, The United States Pharmacopeial Convention, Inc., Rockville, Md. And Physician's Desk Reference, Medical Economics Co., Inc., Oradell, NJ, incorporated herein by reference. The active without sunscreen can be provided as it is or in an encapsulated form. The encapsulation for sun protection additives was previously described. In addition to the encapsulated active, in some embodiments, an additive or composition for topical application containing the active also includes a cationic polymer, as described herein, as well as, optionally, a film former, a preservative and / or an antioxidant. stable when exposed to sunlight. Other components may be as described herein. In some embodiments, the additive or composition for topical application may comprise two, three, four, five, six, seven, eight, nine, ten or more than ten active, each of which may be encapsulated or non-encapsulated, in any combination In preferred embodiments, the active is encapsulated in liquid colloid gel microcapsules such as liquid colloid silica gel microcapsules. Such microcapsules are described in the US Patents. Nos. 6,238,650; 6,436,375; 6,303,149; and 6,468,509. Accordingly, in some embodiments, the invention provides an additive to be added to a composition for topical application, wherein the additive comprises an active without encapsulated sunscreen and further comprises optionally a cationic polymer. In other embodiments, the invention provides a composition for topical application containing an additive, wherein the additive comprises an active without encapsulated sunscreen and optionally further comprises a cationic polymer. Additional ingredients include film formers, antioxidants, preservatives and other ingredients listed herein. The composition for topical application can be e.g., a body bath. In some embodiments, the invention provides microcapsules, e.g., liquid colloid gel capsules (e.g., as described in U.S. Patent Nos. 6,238,650; 6,436,375; 6,303,149; and 6,468,509) that act as a protective barrier on the skin when used either alone or as an additive in a body bath. In these embodiments, the liquid colloid gel microcapsules can be used without any additional active ingredient (? .e., Empty), providing a physical barrier, or can be used with additional encapsulated active ingredients that improve their barrier function. For example, the microcapsules may contain substances that act to visualize toxic agents (e.g., biological or chemical combat agents) or radiation (e.g., alpha, beta or gamma radiation) that partially or completely penetrate the user's skin. In some embodiments, the microcapsules may contain one or more agents that absorb radiation, such as graphite, lead, tungsten and others known in the art, or agents that reflect radiation such as ceramic beads. Since microcapsules can be designed to experience minimal or no breakage when applied to the skin, as well as to experience minimal penetration into the skin, it is possible to use even toxic substances (eg, lead) that provide a visualization effect, due to that these substances were not released or released only in minimal quantities. The microcapsules are eventually removed from the skin by repeated washing and / or normal shedding of the outer cell layers of the skin. Especially for agents used for single or very few exposures, such as may occur with personnel involved in the combat or containment of terrorist or combat attacks, the invention provides a means of providing a last line of defense on the skin of personnel , wherein the active used in the microcapsules may be one not suitable for long-term use, but which is appropriate for a limited number of applications in order to protect the user from a greater risk (eg, microcapsules that encapsulate lead for protection against a radiation attack). The microcapsules, e.g., microcapsules of liquid colloid gel, can be prepared so as to experience minimal or no breakage when applied to the skin either how they are or in the form of a body bath. Alternatively, the microcapsules, e.g., liquid colloid gel microcapsules, can be prepared to undergo varying degrees of breakage, on average, when applied as they are or in a body bath. Accordingly, the microcapsules, eg, liquid colloid gel microcapsules, can be prepared to undergo about 0% break, or a break in a range of about 0.1, 0.5, 1, 2, 5, 10, 20, 30, 40 , 50, 60, 70, 80 or 90% to approximately 0.5, 1, 2, 5, 10, 20, 30, 40, 50, 60, 70, 80 or 90% after application (or application and rinse in the case of a body bath containing the microcapsules). In addition, the microcapsules can be formulated so as to open upon breaking in response to conditions that occur in the skin, so that after application, the microcapsules act to release their contents in a time-controlled or controlled manner. The exemplary non-limiting conditions of the skin or hair that can vary with the user's environment, whose variation can trigger the breakdown of the microcapsules, include pH, temperature, friction, exposure to light or air, pressure and the like. C. Cationic component In some embodiments, the additives, e.g., sunscreen additives and sunscreens / baths of the invention, further include a cationic component. Without being bound by theory, it is believed that this component serves as a protein linker, to provide a positive charge to promote the binding of the composition to the skin and hair proteins, thereby increasing the retention of the components, eg, sunscreen, after rinsing and during normal activities. This positive charge creates a strong affinity for the protein in the hair and skin. Any means can be used to impart a positive charge. Preferred means include one or more cationic polymers in the composition. Various cationic polymers can be used. Examples of cationic polymers are described in the U.S. Patents. Nos. 6,224,852; 3,816,616; 4,272,515; 4,298,494; 4,080,310; 4,048,301; 4,009,256 and 3,186,911. Cationic polymers are commercially available, e.g., from Union Carbide Corp., under the tradename POLYMER JR., From Celanese-Stein Hall under the trademark JAGUAR, from GAF Corporation under the trade name Gafguatum and from Merck & Co., Inc. under the trademark MERQUAT. Representative are Merquat 100, a highly charged cationic dimethyldialkyl ammonium chloride homopolymer and Merquat ™ 550, a highly charged cationic copolymer prepared with dimethyldialkyl ammonium chloride and acrylamide. These materials they are designated in the CTFA dictionary as Quaternium 40 and Quaternium 41, respectively. Polyquaterniums are especially preferred. Quaternized material in powder form can be used, without being limited to polyquaternials. Exemplary polyquaternians for use in the invention include pol? Quatern? Or-4, 7, 11, 22, 37, 44, 51 and 64. Polyquaternium compounds are commercially available, eg, CELQUAT L-200 for pol? Quatern ? o-4. The additional exemplary polyquaterniums can be quaternized copolymers of vmvpyrrolidone, methacrylamide, vinylimidazole and quaternized vinylimidazole and / or vinyl caprolactum. All vary with different load densities. We are mainly concerned about those with higher cationic charges. Some of the new policuaternios that we have not listed are 68, 46, 16. Without being limited by any theory, it is believed that with the entrapment of the encapsulation (eg, active solar protection inside the capsule) by this cationic component, the rinse it becomes difficult and turns the substantive active for the protein into the skin and hair. Useful in some embodiments of the invention, it is a dry cationic component, such as sold under the trade name CAE (Anjmomoto Co., Inc.), which contains DL-pyrrolidone carboxylic acid salt of L-cocoyl arginine ethyl ester, which is a useful cationic agent to join proteins and to provide an antimicrobial effect. In some embodiments of additives, eg, sunscreen additives, the cationic component (eg, cationic polymer) comprises from about 0.1 to about 20%, or from about 0.1 to about 10%, or from about 0.5 to about 10%, or from about 1 to about 10%, or from about 0.5 to about 5%, or from about 0.5 to about 3%, or from about 1 to about 5%, or from about 1 to about 3%, or about 1% of the total composition. In some embodiments, the cationic component is pol? Quatern? O-4; in some embodiments pol? quatern? o-4 is present in approximately 1%. In some active / body bath modalities, eg, sunscreens / body baths, the cationic component (eg, the cationic polymer) comprises from about 0.03 to about 12- or from about 0.03 to about 4% or from about 0.2 to about 4 % or from approximately 0.3 to approximately? 19-, or from about 0.2 to about 2%, or from about 0.3 to about 4%, or from about 0.3 to about 1%, or from about 0.3 to about 0.4% of the composition total. In some embodiments, the cationic component is pol? Quatern? O-4; in some modalities pol? quatern? o-4 is present in approximately 0.33%. D. Film Formers In some embodiments, the compositions of the invention further include a component that provides a film barrier system, typically a hydrophobic layer that serves to maintain the residual sunscreen after rinsing. Film barrier systems are well known in the art and include, without limitation, petrolatum, silicone derivatives and combinations thereof. Polymers with carboxylic ends that become insoluble until neutralized are also useful. After neutralizing they can act as film formers. Film formers also include emollient esters, lanolin derivatives (e.g., acetylated lanolins) and super fatty oils. Film formers are commercially available, e.g., a preferred film former is MOISTUREGUARD ™ containing petrolatum, dimethicone, stearamidopropyl dimethylamine stearate and tocopheryl acetate, available from Engelhard. It may also be desirable to add acrylic copolymers to the formulations of the invention as film formers. An exemplary formulation of liquid acrylic copolymer is DERMACRYL, marketed by National Starch and Chemical. The acrylic copolymers can be included in sunscreen additives from about 0.1 to about 5%, or from about 0.2 to about 3%, from about 0.2%, 0.3%, 0.4% or 0.5% or in sunscreens / body baths of about 0.05 to about 2%, or from about 0.1 to about 1%, or about 0.05%, 0.1%, 0.2%, 0.3%, 0.4%, or 0.5%. A secondary film former, e.g., keratin or other protein derivative in an amino acid complex such as cistern may also be used. The film former can be present in the sunscreen additive in the range from about 0.1 to about 25%, or from about 1 to about 10%; or from about 2 to about 6%; or about 3, 4 or 5%. In some embodiments, the MoistureGuard film former is used in a concentration of approximately 4.2%. Equivalent filmmakers can also be used in equivalent concentrations. As noted, some preparations may perform more than one function, for example, inorganic blockers such as Tioveil and Spectraveil (both of the Tioxide Group), in certain variations, may be filmmakers and may have advantageous uses herein.

In addition, many emollients can also play a role as film barrier since they provide a barrier in the skin. Accordingly, the compositions of the invention may include water-insoluble emollients that include fatty acids such as oleic and stearic; fatty alcohols such as cetyl and hexadecyl (ENJAY); esters such as dusopropyl adipate, esters of benzoic acid of C9-C15 alcohols, and isononyl iso-nonanoate; alkanes such as mineral oil; silicones; such as dimethyl polysiloxane and esters such as polyoxypropylene butyl esters and polyoxypropylene cetyl ethers. If a water-insoluble emollient is used, it may be present in an amount of from about 2% to about 15% by weight and more preferably from about 4% to about 10%. Other useful film formers include polyethylenes such as those available from New Phase Technologies as PERFORMALENE 400, a polyethylene having a molecular weight of 400. Another suitable waterproofing agent is polyethylene 2000 (molecular weight of 2000) which is available from New Phase Technologies as PERFORMALENE 2000. Still another suitable film / water-forming agent is synthetic wax, also available from New Phase Technologies as PREFORM V-825. Still another agent Film-maker / suitable waterproof is octadecene copolymer / MA. Additional film formers that may also be used within the scope of the invention include any film-forming chemicals known in the art. accordingly, suitable additional film formers include acacia gum, cellulose derivatives, guar derivatives and all those described on pages 68-69 of C.T.F.A. Cosmetic Ingredient Handbook, First Edition, 1988, which is incorporated herein by reference. Such film formers include copolymer acrylamide, acplamide / sodium acrylate copolymer, acrylate / acrylamide copolymer, acrylate / ammonium metaplate copolymer, acrylate copolymers, acplate / diacetonecplamide copolymer, acrylic / acrylate copolymer, adipic acid copolymer / dimethylaminohydroxypropyl diethylene-amine, copolymer of adipic acid / dimethylaminohydroxypropyl diethylbenzane, copolymer of adipic acid / epoxypropyl / diethylenetriamine, albumen, allyl stearate / VA copolymer, aminoethyl acyl phosphate / acrylic copolymer, ammonium copolymer acutates, ammonium alginate, ammonium vinyl acetate copolymer / acrylates, copolymer of AMP acrylates / diacetoneacrylamide, gum balsam, oregon balm, peru balm, tolu balm, copolymer of benzoic acid / phthalic anhydride / pentaeptritol / neopentyl glycol / palmitic acid, benzoin extract, butadiene / acrylonitrile copolymer, butylated formaldehyde urea, butyl benzoic acid / t-methyl ethyl acetate anhydride copolymer, anhydrous ethylene copolymer butyl ester maleic, PVM / MA copolymer butyl ester, carrtageenean calcium, calcium / sodium copolymer PVM / MA, carboxymethyl hydroxyethyl cellulose, cellulose gum, collodion, copal, maize starch / acylamide / sodium acrylate copolymer, damar, diethylene copolymer glycolamine / epichlorohydrin / piperazm, DMJ-IF, copolymer of dodecanodoic acid / ceteapl alcohol glycol, ethylcellulose, ethylene copolymer / acrylic copolymer, ethylene / maleic anhydride copolymer, ethylene / vinyl acetate copolymer, PVM / fvIA copolymer ethyl ester, colodian flexible, benzoin gum, gutta percha, hydroxybutyl methylcellulose, hydroxyethylcellulose, hydroxyethyl ethyl cellulose, hydroxypropylcellulose, hydroxypropylgu ar, hydroxypropyl methylcellulose, PVM / MA copolymer isopropyl ester, maltodextpna, melamma / formaldehyde ream, methacryloyl ethyl betatainmethacrylate copolymer, nitrocellulose, octylacrylamide / acrylates / butylammoethylmethacrylate copolymer, octylaplamide / acrylate copolymer, phthalic anhydride / glycepine copolymer decanoate, copolymer phthalic / tpmethyl / glycols, polyacrylamide, polyacylamidomethylpropane sulfone acid, polyacrylate acid, polybutylene terephthalate, polychlorotropfluoroethylene, polyethylacetoxide, polyethylene, polyethylene terephthalate, polnosobutene, polyquaternium 1, polyquaternium 2, pol? quatern? -4, polyquaternium 5, polyquaternium 6, polyquaternium 7, polyquaternium 8, polyquaternium 9, polyquaternium 10, polyquaternium 11, polyquaternium 12, polyquaternium 13, polyquater 14, polyquaternium 15, polystyrene, polyvinyl acetate, polyvinyl alcohol, polyvinyl butyral, polyvinylimidazolinium acetate, polyvinyl laurate, polyvinyl methyl ether, potassium carrageenan , PVM / MA copolymer, PVP, PVP / dimethylaminoethylmethacrylate copolymer, PVP / eicosene copolymer, PVP / ethyl methacrylate / methacrylic acid copolymer, PVP / hexadecene copolymer, PVP / VA copolymer, PVP / vinyl acetate copolymer / itaconic acid, rosm, serum albumin, shellac, sodium acrylate copolymer / vinyl alcohol, sodium carrageen, polymer sodium sulphate, sodium polystyrene sulfonate, starch copolymer / acrylates / acrylamide, diethylaminoethyl ether starch, esteaplvinyl ether / maleic anhydride copolymer, styrene copolymer / acrylic acid / acrylonitrile, styrene / acrylate / ammonium copolymer, metacrate, styrene / anhydride copolymer maleic, styrene copolymer / PVP, copolymer of sucrose benzoate / sucrose acetate isobutyrate / butyl benzyl phthalate, copolymer of sucrose benzoate / sucrose acetate isobutyrate / butyl benzyl phthalate / methyl methacrylate, copolymer of sucrose benzoate / sucrose acetate isobutyrate, toluenesulfonamide / formaldehyde resin, gum tragacanth, vinyl copolymer acetate / crotonates, vinyl acetate / crotonic acid copolymer, vinyl acetate / crotonic acid / methacryloxybenzophenone-1 copolymer, vinyl acetate / crotonic acid / vinyl neodecanoate and ziena copolymer. Additional film formers include those described in the US Patents. Nos. 6,838,419; 6,838,088; 6,780,422; 6,531,118; and 5,916,541, all of which are incorporated herein by reference. E. Other Components A wide variety of components may be added to the compositions of the present invention, provided that the components are selected so as to avoid any undesirable reaction with the major components (eg, one or more of the sunscreen agents) of the composition. The CTFA Cosmetic Ingredient Handbook, Seventh Edition, 1997 and the eighth edition, 2000 (incorporated by reference herein) provides a broad source of potential cosmetic and pharmaceutical ingredients typically used in skin care compositions.

Examples of such additional components include one or more of the following: absorbers, abrasives, antiquated agents, antifoaming agents, binders, biological additives, buffering agents, bulking agents, chelating / sequestering agents (eg, EDTA disodium), chemical additives, dyes, cosmetic astringents, cosmetic biocides, denaturing agents, astringent drugs, emollients (including, aleo vera glycerin and vitamins A, C and D [moisturizing agents and skin protectors]), foam enhancers, fragrance components, gums, humectants / humidifiers (including urea, guanidine, glycolic acid, polyhydric alcohols such as sorbitol, glycerin, hexanotpol, polypropylene glycol, hexylene glycol and the like, polyethylene glycol, sugars and starches, sugar and starch derivatives, D-panthenol, hyaluronic acid, lactamide monoethanolamine , acetamide monoethanolamine and mixtures thereof), hydrotropes, neutralizing agents, agents of opacity and pigments, pH adjusters, plasticizers, preservatives, propellants, reducing agents, skin bleaching agents, skin protectants, solubility agents, suspending agents (e.g., Carbomer 1382). In some embodiments, the additives and body baths of the invention, e.g., sunscreen additives or sunscreens / body baths include a preservative. Exemplary preservatives useful in the invention include citric acid, tartaric acid, phosphoric acid, amino diacetic acid, nitropotriacetic acid, hydroxyethyleneaminodiacetic acid and ethylenediaminetetraacetic acid and salts thereof; para-hydroxybenzoates such as butyl paraben, methyl paraben and propyl paraben; iimidazolines (e.g., imidazolylurea), tpclosan, hindantoins (e.g., dimethyloldimethylthindantoin), isothiazolidinone compounds and mixtures thereof. Commercially available condoms include KATHON CG and KATHON CGII, which contain methylchloroisothiazolinone and methylisothiazolinone (Rohm and Haas). When present, the amount of the preservative is in the range of 0.001 to 2%, preferably 0.01 to 0.2%. In certain embodiments, the compositions of the invention include a chelating agent. Chelating agents are substances used to chelate or bind metal ions, such as with a heterocyclic ring structure so that the ion is held by chemical bonds from each of the participating rings. Suitable chelating agents include ethylene diaminetetraacetic acid (EDTA), disodium EDTA, calcium disodium edetate, EDTA tpsodium, EDTA tetrasodium and EDTA dipotasium. One or more chelating agents may optionally be included in the additives or bath additives / baths in fluctuating amounts of about 0.001 to about 0.2 percent by weight, or about 0.01% percent by weight. Thickening or gelling agents may be added as desired to adjust the texture and viscosity of the composition. Exemplary agents or gelling agents can be selected from Carbopol ™ resins [eg, 934, 971, 974, 980, 981] and Pemulen ™ [TR-1 and TR-2] [both Carbopol ™ and Pemulen ™ are registered trademarks of BF Goodrich] , Noveon AA-1, ETD resins and Ultrez ™ resins [trademark, BF Goodrich]. In addition, the carbomeros can be useful for this purpose. It may be desirable to include a non-polar wax. Examples of such useful waxes include ester waxes, diester waxes, hydrocarbon waxes, silicone waxes and triglyceride waxes and mixtures thereof. Other components may include a liquid hydrocarbon (similar to pentane) and / or a foaming cationic agent derived from arginine and / or cistern. Additional optional ingredients that may be present in the composition include fragrances, colorants, antimicrobial materials such as triclocarban, triclosan iodophors, iodine formulations, phenolic compounds, e.g., hexachlorophene and bisguanides, e.g., chlorhexidene gluconate and the like. See, e.g., US Patents. Nos. 6,827,795; 6,517,854; 6,010,817; 5,173,216; 5,719,113; 5,259,984; 5,562,912; 5,629,006; ,728,662; 5,767,163; 5,750,579; 5,591,442; 5,650,143; 5,772, 640; and 4, 78, 821. The components of the composition are generally mixed in water. F. Surfactants and body baths The compositions of the invention can be formulated as skin care products, for example, bath or shower gels, hand washing compositions or facial cleansing liquids; and products before and after shaving; rinses, skin care products that are removed or left behind; products for hair washing and for dental use. Shower gels are particularly preferred forms of products. If it is desired to prepare a sunscreen / body bath composition, the sunscreen additives of the invention can be combined with other ingredients to produce a body wash (e.g., a liquid or solid formulation). The sunscreen / body bath may include one or more surfactants. The use of surfactants in body baths is well known in the art. any surfactant known in the art and suitable for a body bath composition can be used. See, Detergents & Emulsifiers by McCutcheon, M.C. Publishing Co. (North American edition 1989); Schwartz et al., Surface Active Agents, Their Chemistry and Technology. New York, Interscience Publishers, 1949 and the Patents of E.U Nos 6,096, 697 4, 741, 855, 4,788,066 5, 104, 646; 5, 106, 609 2, 658,072 2,438,091 2, 528,378 2, 486, 921; 2,486, 922 2,396,278 2, 979, 465 3, 179,599 5,322, 643; 5,084,212 3,332, 880 4, 122, 029 4,265,878 4, 421,769; 3,929, 678 3,959,461; 4,387,090; 4,303,543; and 6,224,852; and in British Patents Nos. 848,224 and 791,415. See also CTFA Cosmetic Ingredient Dictionary, 4th edition 1991, pages 509-514 for various long chain cationic alkyl surfactants; and Richmond, James M., Cationic Surfactants, Marcel Dekker, Inc., New York and Basel 1990. The surfactant (s) may be cationic, anionic, non-ionic, zwitterionic, amphoteric or any combination thereof. same. Specific examples of anionic surfactants include those selected from the group consisting of alkyl and alkyl ether sulphates, sulphated monoglycerides, sulfonated olefins, alkyl aryl sulfonates, primary or secondary alkane sulfonates, alkyl sulfosuccinates, acyl taurates, acyl isethionates, alkyl glyceryl sulfonate, methyl esters sulfonates, sulfonated fatty acids, alkyl phosphates, ethoxylated alkyl phosphates, acyl glutamates, acyl sarcosinates, alkyl sulphoacetates, acylated peptides, alkyl ether carboxylates, acyl lactylates, anionic fluorosurfactants and combinations thereof. May combinations of ammonium surfactants may be used effectively in the present invention. Specific examples of alkyl sulfates which may be used are sodium, ammonium, potassium, magnesium or TEA salts of lauryl or myristyl sulfate. Examples of alkyl ether sulfates that may be used include ammonium, sodium, magnesium, or TEA laureth-3-sulfate. Another suitable class of ammonium surfactants are the sulfated monoglycerides of the formula RlCO-0-CH-C (OH) H-CH2-0-S03M, wherein Rl is a saturated or unsaturated, branched or unbranched alkyl group of about 8. to about 24 carbon atoms and M is a water-soluble cation such as ammonium, sodium, potassium, magnesium, triethanolamm, diethanolamm and monoethanolamine. An example of a sulfated monoglypide is sodium cocomonoglycedo sulfate. Other suitable ammonium surfactants include olefin sulphonates of the formula R1S03M, wherein R1 is a mono-olefin having from about 12 to about 24 carbon atoms and M is a water-soluble cation such as ammonium, sodium, potassium, magnesium, triethanolamm , diethanolamm and monoethanolamine. An example of a sulfonated olefin is sodium C14 / C16 alpha olefin sulfonate. Other suitable anionic surfactants are the linear alkylbenzene sulphonates of the formula R1-C6H4-S03M, wherein R 1 is a saturated or unsaturated, branched or unbranched alkyl group of about 8 to about 24 carbon atoms and M is a water soluble cation such as ammonium, sodium, potassium, magnesium, tpetanolamine, diethanolamine and monoethanolamine. An example of an ammonium surfactant is sodium dodecylbenzene sulfonate. Still other suitable ammonium surfactants for the compositions of the present invention include the primary or secondary alkane sulphonates of the formula R1S03M, wherein R1 is a saturated or unsaturated, branched or unbranched alkyl chain of about 8 to about 24 carbon atoms and M is a water soluble cation such as ammonium, sodium, potassium, magnesium, tpetanolamine, diethanolamine and monoethanolamine. An example of a useful alkane sulfonate herein is alkali metal or C13-C17 ammonium paraffin sulfonates. Still other suitable ammonium surfactants are the alkyl sulfosuccinates, which include disodium N-octadecylsulfosuccinamate; diammonium lauryl sulfosuccinate; tetrasodium N- (1, 2-d? carbox? et? l) -N-octadecylsulfosuccinate; sodium sulfosuccinic acid diaryl ester; diethyl ester of sodium sulfosucci co; and dioctyl esters of sodium sulfosuccimic acid. Taurates based on taurine are also useful. Examples of taurates include N-alkyltauphins such as prepared by reactivating dodecylamine with sodium εethionate as detailed in the U.S. Patent. No. 2,658,072. Another class of suitable ammonium surfactant is acyl-isethionate. Non-limiting examples of these acyl ions include ammonium cocoyl εethionate, sodium cocoyl εethionate, sodium lauroyl εethionate and mixtures thereof. Still other suitable ammonium surfactants are the alkyl glyceryl ether sulfonates of the formula R1-OCH2-C (OH) H-CH2-S03M, wherein R1 is a saturated or unsaturated, branched or unbranched alkyl group of about 8 to about 24 atoms of carbon and M is a water-soluble cation such as ammonium, sodium, potassium, magnesium, triethanolamine, diethanolamine and monoethanolamine. An example is sodium cocoglyceryl ether sulfonate. Other suitable ammonium surfactants include: sulfonated fatty acids of the formula R1-CH (S04) -COOH and sulfonated methyl esters of the formula R1-CH (S04) -CO-0-CH3, wherein R1 is a saturated or unsaturated alkyl group saturated, branched or unbranched from about 8 to about 24 carbon atoms, (eg, alpha sulfonated coconut fatty acid and lauryl methyl ester); phosphates such as monoalkyl, dialkyl and trialkyl phosphate salts formed by the reaction of phosphorous pentoxide with branched or unbranched monohydric alcohols having from about 8 to about 24 carbon atoms; carbon (e.g., sodium mono or dilauplfosfato, ethoxylated monoalkyl phosphates, etc.); acyl glutamates corresponding to the formula R1C0-N (COOH) -CH2CH2-C02M wherein R1 is a saturated or unsaturated, branched or unbranched alkyl or alkene group of about 8 to about 24 carbon atoms and M is a cation soluble in water (eg, sodium lauroyl glutamate and sodium cocoyl glutamate); alkanoyl sarcosinates corresponding to the formula R1C0N (CH3) -CH2CH2-C02M wherein R1 is a saturated or unsaturated, branched or unbranched alkyl or alkenyl group of about 10 to about 20 carbon atoms, wherein M is a cation soluble in water (eg, sodium lauroyl sarcosinate, sodium cocoyl sarcosinate and ammonium lauroyl sarcosinate); alkyl ether carboxylates corresponding to the formula R1- (0CH2CH2) x-0CH2-C02M wherein R1 is a saturated or unsaturated, branched or unbranched alkyl or alkenyl group of from about 8 to about 24 carbon atoms, x is from 1 to 10 and M is a water-soluble cation (eg, sodium laureth carboxylate); acyl lactylates corresponding to the formula RICO- [O-CH (CH 3) -CO] x-C02M wherein R 1 is a saturated or unsaturated, branched or unbranched alkyl or alkene group of about 8 to about 24 carbon atoms, x is 3 and M is a water-soluble cation (eg, sodium cocoyl lactylate); carboxylates, whose non-limiting examples include sodium lauroyl carboxylate, sodium cocoyl carboxylate and ammonium lauroyl carboxylate; ammonium fluorosurfactants; and natural soaps derived from the saponification of vegetable and / or animal fats and oils, examples of which include sodium laurate, sodium myristate, palmitate, stearate, talowate, cocoate. Any counter cation M, can be used in the ammonium surfactant. Preferably, the counter cation is selected from the group consisting of sodium, potassium, ammonium, monoethanolamine, diethanolamine and triethanolamine. Non-limiting examples of nonionic surfactants that may be included in the compositions of the present invention, include those selected from the group consisting of alkyl glucosides, alkyl polyglycosides, polyhydroxy fatty acid amides, alkoxylated fatty acid esters, sucrose esters, amine oxides and its mixtures. Alkyl glucosides and alkyl polyglucosides are useful herein and can be broadly defined as condensation products of long chain alcohols, eg, C8-30 alcohols, with sugars or starches or polymers of sugar or starch,? .e., Glycosides or polyglycosides. These compounds can be represented by the formula (S) n-O-R wherein S is a sugar residue such as glucose, fructose, mannose and galactose; n is an integer from about 1 to about 1000 and R is a C8-30 alkyl group. Examples of long chain alcohols from which the alkyl group include decyl alcohol, cetyl alcohol, stearyl alcohol, lauryl alcohol, mipstilic alcohol, oleyl alcohol and the like. Preferred examples of these surfactants include those wherein S is a glucose residue, R is a C8-20 alkyl group and n is an integer of from about 1 to about 9. Commercially available examples of these surfactants include decyl polyglucoside (available as APG 325 CS from Henkel) and lauryl polyglucoside (available as APG 600CS from Henkel). Also useful are sucrose ester surfactants such as sucrose cocoate and sucrose laurate. Other useful nonionic surfactants include fatty acid polyhydroxy amide surfactants, the most specific examples of which include glucosamides. The processes for making the compositions containing polyhydroxy fatty acid amides are described, for example, in the specification of Great Britain Patent 809,060, published February 18, 1959, by Thomas Hedley & Co. , Ltd .; Patent of E.U. No. 2,965,576 for E.R. Wilson, issued December 20, 1960; Patent of E.U. No. 2,703,798 for A.M. Schwartz issued March 8, 1955; and the U.S. Patent. No. 1,985,424 for Piggott issued December 25, 1934. Other examples of nonionic surfactants include amine oxides. The amine oxides correspond to the general formula R? R2R3 N- > 0, wherein Ri contains an alkyl radical, alkenyl or monohydroxy alkyl of from about 8 to about 18 carbon atoms, from 0 to about 10 ethylene oxide residues and from 0 to about 1 glyceryl residues and R2 and R3 contain from about 1 to about 3 carbon atoms and from 0 to about 1 hydroxy groups, eg, methyl, ethyl, propyl, hydroxyethyl, or hydroxypropyl radicals. The arrow in the formula is a conventional representation of a semipolar union. Examples of amine oxides suitable for use in this invention include dimethyl dodecylamine oxide, oleyl di (2-hydroxyl et al) amine oxide, dimethyloctylamine oxide, dimethyl decylamemido, dimethyl tetradecylamine oxide, 3,6,9 -trioxaheptadecildietilamma oxide, di (2-h? drox? et? l) -tetradecylamine oxide, 2-dodecox? et? ld? met? lamma oxide, 3-dodecox? -2-h? drox? prop? ld? (3-hydroxypropylene) amine oxide, dimethylhexadecylamine oxide. The term "amphoteric surfactant", as used herein, is also intended to encompass zwitterionic surfactants, which are well known to formulators skilled in the art as a subset of amphoteric surfactants. A wide variety of amphoteric foamy surfactants can be used in the compositions of the present invention. Particularly useful are those that they are broadly described as derivatives of secondary and tertiary aliphatic amines, preferably wherein the nitrogen is in a cationic state, in which the aliphatic radicals can be straight or branched chain and wherein one of the radicals contains an insoluble group soluble in water, eg, carboxy, sulfonate, sulfate, phosphate or phosphonate. Non-limiting examples of amphoteric surfactants or zwitepomcos are those selected from the group consisting of betaines, sultaines, hydroxysultams, alkylimmoacetates, iminodialkanoates, aminoalkanoates and mixtures thereof. Examples of betaines include higher alkyl betaines, such as coconut dimethyl carboxymethyl betaine, laupl dimethyl carboxymethyl betaine, lauryl dimethyl alphacarboxyethyl betaine, cetyl dimethyl carboxymethyl betama, cetyl dimethyl betama (available as Lonzaine 16SP from Lonza Corp.), laupl bis- (2 -h? drox? et?) carboxymethyl betaine, oleyl dimethyl gamma-carboxypropyl betaine, lauryl bis- (2-hydroxypropyl) alpha-carboxyethyl betaine, coco dimethyl sulfopropyl betaine, lauryl dimethyl sulfoethyl betaine, lauryl bis- (2-h? drox? et? l) sulfopropyl betaine, amidobetaines and amidosulfobetaines (where the radical RCONH (CH. sub .2). sub .3 is bound to the nitrogen atom of betaine), oleyl betama (available as Velvetex OLB-50 amphoteric Henkel) and cocamidopropyl betaine (available as Velvetex BK-35 and BA-35 from Henkel). Examples of sultaines and hydroxysultaines include materials such as cocamidopropyl hydroxysultaine (available as See Me CBS from Rhone-Poulenc). Examples of amphoteric surfactants of the present invention include the following compounds: cetyl dimethyl betaine (this material also has the designation CTFA cetyl betaine); cocamidopropylbetaine; cocamidopropyl hydroxy sultaine. Examples of other amphoteric surfactants are alkyliminoacetates, and imidodialkanoates and ammoalkanoates of the formulas RN [(CH2) C02M] 2 and RNH (CH2) .mC02 M wherein m is from 1 to 4, R is a C8-C22 alkyl or alkenyl and M is H, alkali metal, alkaline earth metal ammonium, or alkanolamome. Imidazole and ammonium derivatives are also included. Specific examples of suitable amphoteric surfactants include sod-3-dodecyl-amidopropionate, sod-3-dodecylaminopropane sulfonate, N-higher alkyl aspartic acids such as those produced according to the teachings of the US Patent 2,438,091; and the products marketed under the trade name "Miranol" and described in the U.S. Patent. No. 2m528,378. Other examples of useful amphotericics include amphoteric phosphates, such as coamidopropyl PG-dimonium chloride phosphate (commercially available as Monaquat PTC, from Mona Corp.). also useful are amphoacetates such as disodium lauroamphodiacetate, sodium lauroamphoacetate and mixtures thereof. In preferred embodiments, the sunscreens / body baths of the invention include at least one cationic surfactant. Many cationic surfactants are known in the art. Suitable cationic surfactants include, but are not limited to, fatty amines, quaternary di-fatty amines, tp-quaternary fatty amines, quaternary amidazole amines, and combinations thereof. Suitable fatty amines include quaternary monoalkyl amines such as cetyltrimethylammonium bromide. A suitable quaternary amine is dialkylamidoethyl hydroxyethylammonosulfate. By way of example, the following may be mentioned: steamphodimethylbenzyl ammonium chloride; dodecyltrimethylammonium chloride; Nomethylbenzylethyldimethyl ammonium nitrate; tetradecylpyridinium bromide; chloropyridyl chloride; cetylpipdime chloride; laurylpipdimide chloride; lauplisoquinolin bromide; ditalow (hydrogenated) dimethyl ammonium chloride; dilaupldimethyl ammonium chloride; and stearalkonium chloride. Additional catimic surfactants are disclosed in the U.S. Patent. No. 4,303,543, see column 4, line 58 and column 5, lines 1-42, incorporated herein by reference. See also CTFA Cosmetic Ingredient Dictionary, 4th edition 1991, pages 509-514 for various long chain alkyl cationic surfactants; incorporated herein by reference. Total surfactants, eg, cationic surfactant, may be present in the sunscreen / body bath in from about 0.1 to about 20%, or from about 0.1 to about 10%, or from about 0.1 to about 5%, or about 0.5. to about 5%, or from about 1 to about 10%, or from about 1 to about 5%, or from about 0.1 to about 2%, or from about 1 to about 2%. In some embodiments, the sunscreen / body bath composition of the invention contains a surfactant, e.g., a cationic surfactant in about 1%. In addition to the surfactants, other ingredients may be included, as described above for additives in the body bath / additive. Any component known in the art or useful in body baths can be used. In some embodiments, non-soap cleaners may be used in addition to or in place of soaps / surfactants. For example, Oilatum ™ AD (registered trademark, Stiefel Laboratories), Aquaml ™ (trademark) may be used.

Registered Person & Covey, Inc.), Cetaphil ™ (trademark, Galderma Laboratories, Inc.) or SpectroDerm ™ (trademark Draxis Pharmaceutical Inc.), or their equivalents, as a non-soap component in the present invention. As noted above, the sunscreen additives of the invention can also be combined with conventional body bath compositions, as well as with hair shampoos and post-wash skin care compositions. The proportions for addition and mixing were given above as well as in greater detail below. An exemplary body bath that can be used with the additives of the invention is exemplified by the SOFT Body Wash. The ingredients of a typical SOFT body bath include: water, ammonium lauryl sulfate, ammonium laureth sulfate, cocamidopropyl betaine, fragrance, glycepna, hydrolyzed milk protein and honey extract, PEG-10 sunflower glycemic, cocamide MEA, guar hydroxypropylpmonium chloride, copolymer of acrylates, cocamide PEG-5, Helianthus annus seed oil (sunflower) or soy glycine oil (soybean), tetrasodium EDTA, propylene glycol, ammonium chloride, sodium hydroxide, methylchloroisothiazolinone, methylisothiazolinone, titanium dioxide / Cl 77891). II. Methods A. Preparation The compositions of the invention can be prepared by any suitable method. In a preferred embodiment, a "Phase I" that is in "aqueous phase" is prepared, mixing the most water-soluble components of the composition. For example, polyester quatern-4, a film former (e.g., in MOISTUREGUARD) and an encapsulated sunscreen (e.g., in UV PEARLS) may be mixed until uniform. A "Phase II" which is in the "oil phase" is prepared by mixing the most hydrophobic components of the composition. For example, avobenzone (e.g., PARSOL 1789) can be mixed with octocplene, with heating, until dissolved. Then Phase I and Phase II are combined with gentle agitation, until a uniform composition is obtained (Phase III). Phase III may also be combined with a body bath composition (e.g., SOFT body bath) and mixed until uniform. An additional sunscreen, such as titanium dioxide, may be added to the Phase III / body bath composition and mixed until uniform. Alternatively, the sunscreen can be added before being added to the body bath or soap to provide an additive ready to be formulated with a body wash or soap. B. Use The additives, e.g., sunscreen additives of the invention, are generally designed for use in combination with a body bath. Therefore, the Compositions of the invention are typically designed to be applied during washing. This feature facilitates use and may have the added benefit of being cumulative. The compositions of the present invention are easily applied during washing in a suitable or effective amount and can be applied generally throughout the body. Shampoos can be applied specifically to hair. A selected amount of a composition can be applied directly to the skin or can be used by intermediate application to a scourer, pad, sponge or other applicator. After foaming, dirt or dusted skin can be washed by rinsing with water leaving behind one or more of the additives, e.g., sunscreen components. The additives of the invention, e.g., sunscreen additives of the invention are also useful in shampoos and conditioners for hair and in aftershave lotions. Accordingly, the methods of the invention include methods for the protection of the skin from sunlight, comprising the application of a body bath comprising a sunscreen for the skin, wherein, after the application of the body bath to the skin. skin and rinse, the skin is protected from sunlight with an average SPF of at least about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more than 20.

In some preferred embodiments, the skin is protected from sunlight with an average SPF of at least about 2. In some preferred embodiments, the skin is protected from sunlight with an average SPF of at least about 5. In some preferred embodiments, the skin is protected from sunlight with an average SPF of at least about 10. In some preferred embodiments, the skin is protected from sunlight with an average SPF of at least about 15. In some embodiments, body bath is applied more than once; in these cases, the SPF can be cumulative and can be increased with the second wash at, eg, an average of more than 2, 5, 6, 7, 8, 9, 10, 11, 12, 13, 15, 16, 17 , 18, 19, 20, 21, 22, 23, 24, 25, 30, 35, 40, 45 or more than about 45. In some embodiments the body bath is applied once a day. In some modalities the body bath is applied more than once a day, for example, 2, 3, 4 or more than 4 times a day. In some modalities, the body bath is applied approximately every third day. In some modalities, the body bath is applied approximately 10, 8, 7, 6, 5, 4, 3, 2 or 1 time a week. In these methods, the active additive, e.g., sunscreen, often does not penetrate beyond a certain level into the skin, typically due to encapsulation. Therefore, in some modalities of the methods of invention the active additive, e.g., sunscreen, does not penetrate more than about 10, 20, 25, 30, 35, 40, 45 or 50 microns into the skin with a wash with a body bath containing the additive. In some embodiments, the active additive, eg, sunscreen, does not penetrate more than about 10, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 120 or 150 microns in the skin, even with repeated washes. In other embodiments, the sunscreen or other additive is designed to penetrate the skin, therefore, in these modalities. The active additive, e.g., sunscreen, penetrates at least about 10, 20, 25, 30, 35, 40, 45 or 50 microns into the skin with a wash with a body bath containing the additive. In some embodiments, the active additive, eg, sunscreen, penetrates more than about 10, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 120 or 150 microns into the skin . In some modalities, this penetration occurs with a single wash and rinse. In some modalities, this penetration occurs with repeated washing and rinsing. Any of the additives described herein, e.g., sunscreen additives, generally as a component of a body bath, can be used in the methods of the invention. In some embodiments, the additive is a non-sunscreen additive and is found encapsulated, e.g., in the form of liquid colloid gel microcapsules. In these embodiments, the additive may be used in combination with a non-body bath vehicle, such as skin lotion, gel, cream and the like, as are known in the art. Although the use of the compositions is commonly preferred in a manner similar to ordinary soap (? .e., Wetting, application of the composition, rinsing), it is also anticipated that the composition may be used by application without wetting followed by removal, example, by rubbing. This is the case of non-soap cleaners. C. Marketing Methods The invention also encompasses methods for marketing in the field of topical delivery of pharmaceutical cosmetics and the transdermal supply of pharmaceuticals using foaming products, including common soap and shampoo, as delivery agents. Consumers spend more than $ 30 trillion annually on products that take advantage of topical and transdermal delivery methods. Despite the enormous growth in this area, there have been very few important innovations. Most delivery methods are still based on lotions, creams or patches. By combining a cosmetic or even pharmaceutical regimen with a routine activity such as washing or bathing, the commercial methods of the invention capture a significant part of the topical and transdermal supply market. The products allow producers of personal care products to secure part of the growing market for pharmaceutical cosmetics, such as sunscreen, by improving existing production lines. They also allow drug producers to offer consumers more attractive ways to administer the prescription and the pharmacists on display. The methods of commercialization of the invention encompass a method for marketing which comprises marketing an additive for use with an existing body bath, wherein the additive, when combined with the body bath, produces an effect in addition to the normal effect of the soap or body bath . Commercialization methods include methods that involve any of the additives described herein, including sunscreens, insect repellents, anti-acne medications, anti-wrinkle agents, deodorants and all those described herein. In some embodiments, methods include the commercialization of a beneficial sunscreen agent (additive) for use with a body bath, e.g., bar and liquid soaps and shampoos, to add a benefit to sunscreen. The sunscreen can be any of the sun protection additives described herein. This modality is designed to attract soap manufacturers who seek to expand the market for their products among the growing population of consumers concerned with skin cancer and wrinkles. Generally, the beneficial agent is marketed as a neutral brand additive for use with existing brands. In some cases, an autonomous brand can be created. Sunscreen or other beneficial agent can be licensed as an additive, in both liquid and bar soapy forms, for producers of personal care products of all sizes, to improve and differentiate their branded product offerings. The license can be exclusive or, preferably, non-exclusive. If it is exclusive, it can be exclusive in a defined geographic territory, for a defined period of time (often with the option to renew the rights of first rejection at the expiration of the period of time), for a defined type of product for skin care. , or any combination of these. The methods also include the supply of one or more customers with an option to license or purchase the additive, generally for a defined period of time. As with licenses, such option may be exclusive or non-exclusive. Alternatively, the sunscreen or other beneficial agent can be manufactured and supplied to the producers of products for personal care. An additional alternative is to manufacture an autonomous soap / body bath brand that includes the additive. An additional component of the methods of commercialization of the invention, typically includes receiving payment for the supply of the additive, license or the like, of the customer. It will be appreciated that the "payment" can be any considered form, including monetary consideration. Typically, license payments take the form of a front-end payment, concessions, license maintenance taxes or some combination thereof. Equity in the company that receives the additive or license for the additive are also included in the payment options. It will be appreciated that any other form of consideration may also constitute a payment in the marketing methods of the invention. The methods of commercialization of the invention can also include the manufacture of the additive and / or the additive / body bath. In some modalities, different entities perform different aspects; for example, a first entity can manufacture the additive and a second entity can market and / or distribute it. In some modalities, a single entity performs both manufacturing and marketing. The methods of commercialization of the invention they include a method that includes the steps of: a) designing an additive for use in a personal care product; b) test the additive for its safety and effectiveness in humans; c) arrange the distribution and commercialization of the additive. In some embodiments, steps a) and c) are carried out by a first entity, typically a commercial entity and stage b) is carried out by a second entity, such as a commercial entity or an academic entity. In some of these modalities, stage b) is carried out as a partnership between the two entities. All publications and patent applications mentioned in this specification are incorporated herein by reference to the same extent that each publication or individual patent application is specifically and individually indicated by the reference. It will be apparent to one of ordinary skill in the art that many changes and modifications may be made to the descriptions presented herein without departing from the spirit or scope of the appended claims. EXAMPLES EXAMPLE 1 A sunscreen additive to be added to a body bath was prepared as follows: To 13.7 g of water is added 1 g of pol? Quater-4 (CELQUAT-200), 1.5 g of water.

MOISTUREGUARD and 12 g of UV PEARLS. The mixture was stirred until uniform to produce Phase I. Separately, 1 g of PARSOL 1789 was added to 4 g of octocrylene with heating and stirred until uniform, to produce Phase II. Phase I and Phase II were combined with gentle agitation until uniformity to produce Phase III, a sunscreen additive. The Phase III sunscreen additive was added to 64.5 g of SOFT Bodywash and agitated until uniform. Finally, 2.3 g of titanium dioxide were added with stirring. The final composition was a sunscreen / body bath. EXAMPLE 2 The sunscreen / body bath of Example 1 was tested for its SPF capacity as follows: 50 cm2 of the test area was wetted with 10 ml of water supplied with a syringe. The test sample was applied according to the Monograph FDA C.F.R. 21 to the area. The foam was worked on the subject for 3 minutes to allow the product to be absorbed into the skin. The area was rinsed after an additional 2 minutes with 20 ml of water, then the area was patted dry and 15 minutes before exposure to radiation according to the FDA Monograph. The skin was exposed to UV radiation and scored and compared the MED with the MED for the skin without treatment. The Results are shown in the following Table. Table (Foam Method *) MED: minimum erythemal dose I: intensity of the light source This example shows that the sunscreen / body bath improved the sun protection measured by means of this protocol, compared to untreated skin, by an average SPF of up to 18. EXAMPLE 3 A sunscreen / body bath was prepared by mixing the following ingredients: 0.1 to 7.5 parts by weight of octylmethoxy cmamate, 0.1 to 6 parts by weight of octyl salicylate, 0.1 to 5 parts by weight of oxybenzone, 1 to 10 parts by weight of catiomco surfactant, 0.01 to 1 part by weight of a quaternized compound and 0.01 to 1 part by weight of a condom. EXAMPLE 4 A sunscreen / body bath was prepared by mixing the following ingredients: Water 20.65% Pol. Quaternum-4 .01-3.75% Dimethicone .01-7% Octylmetoxic amato on amorphous silica Petrolate .01-10% Titanium dioxide .01 -20% Octocpleno .01-10% Parsol 1789 (avobenzone) .01-3% Kathon .01-2% Generic body wash 5-99% EXAMPLE 5 The generic type soap bases for shampoos, body baths, facial cleansers or specialized washes they can consist of a base such as: Water 45 Dermacryl AQF 4.7 Pol? cuatermo-4 3.8 Cocamido propil betaína Umbetain BA-35 6 Ammonium lauryl sulfate Umpol A 24 Ammonium laureth sulfate Umpol EA-2 6 Dimethicone Moistureguard 10 Preservative 0.5 100 This base shows an example of the addition of a polyquaternium to increase the benefits of SPF added in the mixtures mentioned in the art. The poly-temperature ranges in the base may vary from .001% -10% to the base to improve the system. The addition of additional film formers can also improve the additive, an example being the acrylate copolymer, Dermacryl AQFtm. Acrylates, especially carboxylated aggregates at a level of .0011-20%, being hydrophobic, offer substantial water resistance allowing the final product to be water resistant to a greater degree. These components can be added in their entirety in the soap-based formulation to create a synergistic effect with the additive. EXAMPLE 6 50 subjects were tested with the sunscreen / body bath of Example 1 of the invention by skin irritation. The subjects were bathed or washed in the usual manner, then 0.2 ml or 0.2 g of the test material was delivered over a designated area of the subject's back and dried or air-dried. The procedure was completed nine times consecutive (Monday, Wednesday and Friday for three consecutive weeks). The areas of application were caused by erythema and edema. The subjects were then given a rest for 10-14 days followed by reapplication in another test area, equivalent to any of the nine original exposures. No adverse reactions of any kind were noted during the course of this study. EXAMPLE 7 A water resistance test was carried out using the sunscreen / body bath of Example 1. In accordance with the claims of the FDA monograph for water resistant and very water resistant, the product sample was applied to the skin in dry of the subjects, then submerged in a swirl bath for 40 or 80 minutes prior to measurement. The average SPF after the 40 minute dive was 12.45 and after the 80 minute dive it was 10.35. Although preferred embodiments of the present invention have been shown herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes and substitutions will now be presented to those skilled in the art without departing from the invention. It should be understood that various alternatives to the embodiments of the invention described herein when practicing the invention. It is intended that the following claims define the scope of the invention and that the methods and structures within the scope of these claims and their equivalents be covered by them.

Claims (31)

1. CLAIMS 1. An additive to be added to a body bath, wherein the additive comprises a sunscreen and wherein, when the additive is combined with said body bath, after a single application of the body bath to the skin and of the rinse, the Skin is protected from sunlight with an average SPF of at least about 15.
2. 2. An additive to be added to a body bath, wherein the additive comprises a UVA absorbing sunscreen, a UVB absorbing sunscreen and a protective sunscreen, wherein (i) the UVB-absorbing sunscreen is selected from the group consisting of aminobenzoic acid, cinoxate, dioxybenzone, homosalate, octocrylene, octyl methoxycinnamate, octyl salicylate, oxybenzone, O padinate, phenylbenzimidazole sulfonic acid, sulisobenzene and trolamine salicylate; (n) the UVA absorbent sunscreen is selected from the group consisting of avobenzone and methyl anthranilate; (m) the physical blocker sunscreen is selected from the group consisting of titanium dioxide and zinc oxide and wherein, when the additive is combined with said body bath, after a single application of the body bath to the skin and the rinse, the skin is protected from sunlight with an average SPF of at least about 2.
3. 3. An additive to be added to a body bath, wherein the additive comprises a sunscreen and wherein, when the Additive is combined with said body bath, after a single application of the body bath to the skin and of the rinse, the sunscreen penetrates no more than 50 microns into the skin after the application followed by rinsing.
4. 4. A sunscreen additive composition for adding to a body bath, comprising a UVA absorbent sunscreen, a UVB absorbing sunscreen, a physical sunblock and a cationic polymer.
5. 5. A sunscreen additive to be added to a body bath, comprising a first component comprising a first sunscreen and a cationic polymer and a second component comprising a second sunscreen, wherein the first component and the second component are add to the body bath separately.
6. 6. An additive to be added to a body bath, wherein the additive comprises a sunscreen encapsulated in a sol-gel microcapsule and a cationic polymer.
7. 7. An additive to be added to a body bath, wherein the additive comprises an active without sunscreen that is encapsulated and a cationic polymer.
8. 8. A body bath comprising an additive comprising a sunscreen, wherein after a single application of the body bath to the skin and rinsing, the skin is protected from sunlight with an average SPF of at least about 15.
9. 9 A body bath, comprising an additive comprising a sunscreen, wherein, after application of the body bath to the skin and rinsing, the sunscreen penetrates an average of no more than 30 microns into the skin after the application followed by rinsing.
10. 10. A body bath comprising a UVA absorbing sunscreen, a UVB absorbing sunscreen, a physical sunblock and a cationic polymer.
11. 11. A body bath comprising an additive, wherein the additive comprises an active without encapsulated sunscreen and further comprising a cationic polymer.
12. 12. The additive of claims 1, 2, 3, 4, 5, 8, 9 and 10, wherein the sunscreen is encapsulated.
13. 13. The additive of claim 12, wherein the sunscreen is encapsulated in a sol-gel microcapsule.
14. 14. The additive of claims 1, 2, 3, 8 and 9, further comprising a cationic polymer.
15. 15. The additive of claims 4, 5, 6, 7, 10, 11 and 14, wherein the cationic polymer is a polytetrater.
16. 16. The additive of claim 15, wherein the cationic polymer is polyquaternium -4, -7, -11. -22, -27, -44, -51 or -6.
17. 17. The additive of claim 16, wherein the cationic polymer is pol? Quater-4.
18. 18. The additive of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 13 and 17, further comprising a film former.
19. 19. The additive of claim 18, wherein the film former comprises petrolatum.
20. The additive of claims 12 or 13, wherein the additive further comprises a cationic polymer.
21. 21. The additive of claim 20, wherein the cationic polymer is a polyquater.
22. 22. The additive of claim 21, wherein the cationic polymer is pol? Quater-4.
23. 23. The additive of claims 1, 3, 5, 6, 8, 9, 19 and 22, wherein the sunscreen is a UVB absorbing sunscreen and further comprises a UVA absorbing sunscreen.
24. The additive of claim 23, further comprising a physical sunblock sunscreen.
25. 25. The additive of claim 24, wherein (i) the UVB-absorbing sunscreen is selected from the group consisting of aminobenzoic acid, cinoxate, dioxybenzone, homosalate, octocplene, octyl methoxy amate, octyl salicylate, oxybenzone, O padinate, phenylbenzimidazole acid sulfonam, sulisobenzene and trolamine salicylate; (n) the UVA absorbent sunscreen is selected from the group consisting of avobenzone and methyl anthra- mlate; and (m) the physical blocker sunscreen is selected from the group consisting of titanium dioxide and zinc oxide.
26. 26. A method for preparing a body bath comprising a sunscreen additive comprising a first component comprising a first sunscreen and a cationic polymer and a second component comprising a second sunscreen, the method comprising the combination of the first component with a body bath, then the combination of the second component with the body bath separately.
27. 27. A method for protecting the skin from sunlight, which comprises applying a body bath comprising a sunscreen for the skin, wherein, after applying the body bath to the skin and rinsing, the The skin is protected from sunlight with an average SPF of at least about 15.
28. 28. A method for protecting the skin from sunlight, which comprises applying a body bath comprising an additive comprising a sunscreen for the skin, where the sunscreen penetrates an average of no more than 30 microns into the skin, after the application followed by rinsing.
29. 29. A method for protecting the skin from sunlight, which comprises applying a body bath to the skin, wherein the body bath comprises a UVA absorbing sunscreen, a UVB-absorbing sunscreen, a physical sunblock and a sunscreen. cationic polymer.
30. 30. A marketing method comprising: (a) supplying a customer with an additive to be added to a body bath and (b) receiving payment for said additive.
31. 31. A marketing method comprising: (a) supplying a customer with a license for an additive to be added to a body bath and (b) receiving payment for said license.